Autoimmune hepatitis, wide definition

AUTOHEP_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K75.4, K75.8, K75.9 Cause of death: ICD-10 — K75.4, K75.8, K75.9 2 out of 7 registries used, show all original rules.	2134
4. Check minimum number of events None	2134
5. Include endpoints None	2134
6. Filter based on genotype QC (FinnGen only)	1914

Control definitions (FinnGen only)

Control exclude: AUTOIMMUNE

Extra metadata

First used in FinnGen datafreeze: DF14

NAME	AUTOHEP_WIDE
CONTROL_EXCLUDE	AUTOIMMUNE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K754\|K758\|K759
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K754\|K758\|K759
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Autoimmune hepatitis, wide definition based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Autoimmune hepatitis

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1914	1175	739
Unadjusted period prevalence (%)	0.39	0.42	0.34
Median age at first event (years)	51.62	51.67	51.54

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1985: Matched controls
19850

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

504.3

310.6

302

K76.9

ICD-10 Finland

Liver disease, unspecified

41.0

307.7

270

K75.4

ICD-10 Finland

Autoimmune hepatitis

+∞

307.7

365

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

4503599627370496.0

307.7

1694

A07EA06

ATC

budesonide; oral, local oral

46.8

307.7

326

A05AA02

ATC

ursodeoxycholic acid; oral

46.8

307.7

275

H03AA01

ATC

levothyroxine sodium; systemic

9.3

307.7

455

618

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

9.7

307.7

629

905

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

22.3

307.7

491

288

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

49.7

307.7

478

126

L04AX01

ATC

azathioprine; systemic

112.7

307.7

426

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

15.5

288.4

263

194

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

33.2

271.6

176

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

15.4

239.7

217

157

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

23.6

239.1

175

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.4

222.3

552

1332

A07EC02

ATC

mesalazine; oral, rectal

20.7

212.3

164

L04AA06

ATC

mycophenolic acid; systemic

23.8

201.0

146

K83.0

ICD-10 Finland

Cholangitis

20.6

181.3

140

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

10.5

177.4

205

216

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.7

174.5

854

3340

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.5

158.1

897

3806

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

17.6

153.0

127

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

146.7

139

H02AB06

ATC

prednisolone; systemic

3.3

145.3

1181

6130

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

221.6

140.8

144

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

53.3

125.9

P01BA02

ATC

hydroxychloroquine; oral

8.2

125.0

174

231

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

63.0

120.8

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

63.0

120.8

K74.3

ICD-10 Finland

Primary biliary cirrhosis

624.8

120.5

118

L04AD01

ATC

ciclosporin; systemic

19.6

117.6

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

8.5

114.0

153

194

L01BB02

ATC

mercaptopurine; oral

177.5

112.6

117

Z94.4

ICD-10 Finland

Liver transplant status

58.1

110.2

E03

ICD-10 Finland

Other hypothyroidism

13.7

108.1

102

R94.5

ICD-10 Finland

Abnormal results of liver function studies

12.7

107.8

107

K51.5

ICD-10 Finland

Left sided colitis

286.2

107.0

108

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

11.7

105.4

110

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

8.3

102.1

139

179

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

159.9

101.2

106

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

19.3

99.1

K72.9

ICD-10 Finland

Hepatic failure, unspecified

27.7

98.4

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

33.1

94.8

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

50.4

93.2

L04AX03

ATC

methotrexate; systemic

6.5

93.2

160

266

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

90.4

1069

6223

K70.1

ICD-10 Finland

Alcoholic hepatitis

22.7

90.0

L04AD02

ATC

tacrolimus; systemic

17.9

87.2

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

27.9

83.9

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

15.3

83.9

UJF32

NOMESCO Finland

Coloscopy

2.6

79.5

605

2821

L01BA01

ATC

methotrexate; systemic

26.4

78.0

B18.2

ICD-10 Finland

Chronic viral hepatitis C

10.7

77.8

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

5.9

76.9

144

260

104

Kela drug reimbursment

Thyroid insufficiency

6.7

76.5

125

197

N02AX02

ATC

tramadol; systemic, rectal

2.4

75.3

978

5788

UJF30

NOMESCO Finland

Ileoscopy through colon

3.5

74.7

293

941

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.2

71.8

206

533

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

71.4

869

4969

127

Kela drug reimbursment

Transplant complication

11.8

70.9

H02AB07

ATC

prednisone; oral

3.2

69.7

326

1164

A02BC02

ATC

pantoprazole; systemic

2.5

67.7

1476

10698

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

96.1

67.4

A10AB05

ATC

insulin aspart; parenteral

4.7

67.2

166

382

A10AC01

ATC

insulin (human); parenteral

4.7

66.6

163

372

A07EC01

ATC

sulfasalazine; oral, rectal

5.8

65.1

122

220

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

7.1

64.8

100

148

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

9.1

63.8

K90.0

ICD-10 Finland

Coeliac disease

13.5

62.4

L04AB04

ATC

adalimumab; parenteral

23.0

61.7

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

61.3

520

2510

R50.9

ICD-10 Finland

Fever, unspecified

2.7

61.1

385

1611

L40.0

ICD-10 Finland

Psoriasis vulgaris

10.8

60.6

D97

ICPC

Liver disease NOS

17.1

60.1

A10AB01

ATC

insulin (human); parenteral

14.6

59.7

K75.8

ICD-10 Finland

Other specified inflammatory liver diseases

+∞

59.7

ZX120

NOMESCO Finland

Intravenous

3.3

59.3

242

792

C10AC01

ATC

colestyramine; oral

6.3

58.8

101

167

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

11.0

58.5

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

14.3

58.0

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

58.0

345

1398

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.1

57.6

265

932

UJK02

NOMESCO Finland

ERCP

6.1

56.7

100

170

K50.8

ICD-10 Finland

Other Crohn disease

+∞

56.5

C03DA01

ATC

spironolactone; oral

2.8

54.0

300

1170

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

272.9

52.4

A06AD11

ATC

lactulose; oral

2.7

52.0

336

1415

K51.8

ICD-10 Finland

Other ulcerative colitis

510.6

50.6

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

13.3

50.4

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

50.2

458

2259

XF400

NOMESCO Finland

ECG with 12 standard connections

2.5

48.5

351

1558

C03CA01

ATC

furosemide; systemic

2.2

48.3

558

3026

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.7

48.0

294

1203

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

18.8

46.6

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.3

46.1

124

304

K50.0

ICD-10 Finland

Crohn disease of small intestine

+∞

46.0

A07EA02

ATC

hydrocortisone; rectal

14.9

46.0

JJC00

NOMESCO Finland

Allogenic transplantation of liver

85.5

45.0

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.6

44.7

291

1224

E03.89

ICD-10 Finland

Other specified hypothyroidism

8.1

44.4

L88

ICPC

Rheumatoid/seropositive arthritis

7.6

44.2

J01MA02

ATC

ciprofloxacin; systemic

2.0

43.8

789

4997

L04AA01

ATC

[U] ciclosporin

14.1

43.4

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

+∞

42.9

K50.9

ICD-10 Finland

Crohn disease, unspecified

149.9

41.9

K71.2

ICD-10 Finland

Toxic liver disease with acute hepatitis

68.6

41.2

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

112.5

40.9

T89

ICPC

Diabetes insulin dependent

7.2

40.8

K50.1

ICD-10 Finland

Crohn disease of large intestine

+∞

40.8

A10AB04

ATC

insulin lispro; parenteral

9.1

39.0

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

6.5

39.0

101

A10AE04

ATC

insulin glargine; parenteral

3.0

38.9

182

642

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

38.8

408

2111

B19.9

ICD-10 Finland

Unspecified viral hepatitis without hepatic coma

52.3

38.7

A02BC03

ATC

lansoprazole; oral

2.0

38.5

584

3456

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

384.6

38.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

38.0

309

1436

K75.2

ICD-10 Finland

Nonspecific reactive hepatitis

136.0

37.8

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

+∞

37.6

T86

ICPC

Hypothyroidism/myxoedema

6.7

37.5

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

37.4

496

2796

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

37.2

349

1722

H02AB09

ATC

hydrocortisone; systemic

5.8

37.2

123

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

363.7

36.1

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.9

35.6

177

645

Z2221

NOMESCO Finland

Medical doctor

1.9

35.4

581

3514

R18

ICD-10 Finland

Ascites

4.9

35.2

167

A02BC01

ATC

omeprazole; systemic

1.9

34.9

541

3209

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.4

34.4

207

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

34.3

240

1040

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

33.8

152

523

Z3231

NOMESCO Finland

Registered nurse

1.9

33.5

547

3295

A10AD01

ATC

insulin (human); parenteral

11.9

33.4

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.7

32.7

194

775

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

31.6

340

1762

N05CF01

ATC

zopiclone; oral

1.8

31.5

627

4006

A10AE05

ATC

insulin detemir; parenteral

4.1

31.2

219

A02BC05

ATC

esomeprazole; systemic

1.8

30.9

807

5578

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

111.8

30.7

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.8

30.5

151

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.9

30.4

250

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

5.9

30.2

ZXE00

NOMESCO Finland

One hour or less

1.7

29.9

764

5235

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

29.7

519

3175

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

6.4

29.6

TK800

NOMESCO Finland

Hemodialysis

5.6

29.2

103

K86.1

ICD-10 Finland

Other chronic pancreatitis

9.4

29.2

N05CD07

ATC

temazepam; oral

2.3

29.1

236

1089

A10AA02, ,

ATC

8.5

28.8

J01MA12

ATC

levofloxacin; systemic

2.0

28.7

362

1985

P01AB01

ATC

metronidazole; oral, rectal

1.7

28.3

796

5577

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.2

28.1

114

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

27.8

465

2799

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

27.3

281

1428

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

27.1

467

2835

G35

ICD-10 Finland

Multiple sclerosis

274.7

26.8

B15.9

ICD-10 Finland

Hepatitis A without hepatic coma

274.7

26.8

R11

ICD-10 Finland

Nausea and vomiting

2.4

26.7

198

877

JJA20

NOMESCO Finland

Open biopsy of liver

28.2

26.7

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

98.1

26.7

JJ5AT, ,

NOMESCO Finland

141.9

26.7

UJF92

NOMESCO Finland

Capsular endoscopy

5.0

26.3

117

3AC01, ,

NOMESCO Finland

8.8

26.3

R4190

NOMESCO Finland

Nutritional therapy

3.3

26.3

100

311

L04AC05

ATC

ustekinumab; parenteral

+∞

26.1

107

Kela drug reimbursment

Pernicious anaemia

+∞

26.1

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.0

26.0

198

L04AA13

ATC

[U] leflunomide

24.4

25.7

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

8.2

25.7

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

25.7

719

5001

SPAT1262

SPAT

Handing over of treatment supplies

2.0

25.6

303

1618

J01FF01

ATC

clindamycin; systemic

1.8

25.6

522

3326

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

44.9

25.6

M13.9

ICD-10 Finland

Arthritis, unspecified

2.7

25.4

148

585

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

25.1

168

710

WX892

NOMESCO Finland

Monitored bed care

2.5

25.0

160

662

Z3226

NOMESCO Finland

Physiotherapist

1.9

24.8

359

2054

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.0

24.5

115

405

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

24.4

430

2617

ZXD05

NOMESCO Finland

Urgent procedure

1.7

24.3

581

3861

C07AA05

ATC

propranolol; systemic

1.8

24.3

422

2558

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.8

24.2

125

464

K92.0

ICD-10 Finland

Haematemesis

4.1

24.1

168

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

3.1

24.0

102

339

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

4.9

23.9

111

XF600

NOMESCO Finland

Bloodpressure measurement

2.7

23.9

138

543

B03BA03

ATC

hydroxocobalamin; parenteral

3.5

23.8

249

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.9

23.8

117

423

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

3.7

23.6

207

N06AB04

ATC

citalopram; systemic

1.8

23.5

406

2454

D05AX02

ATC

calcipotriol; topical

4.5

23.4

129

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.4

23.4

176

784

N05BA01

ATC

diazepam; systemic, rectal

2.0

23.4

265

1392

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

7.1

23.4

N03AE01

ATC

clonazepam; systemic

2.7

23.3

126

479

UJD02

NOMESCO Finland

Gastroscopy

3.0

23.0

104

359

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

+∞

23.0

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

23.0

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.1

22.8

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

22.8

201

957

A10AA01, ,

ATC

30.4

22.8

K71.9

ICD-10 Finland

Toxic liver disease, unspecified

84.4

22.7

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

121.4

22.6

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

5.2

22.4

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

32.7

22.4

B17.1

ICD-10 Finland

Acute hepatitis C

45.6

22.4

NH3EA

NOMESCO Finland

Feet X-ray examination with load

6.0

22.2

T90

ICPC

Diabetes non-insulin dependent

1.8

22.0

442

2786

N05AH04

ATC

quetiapine; oral

1.9

22.0

350

2058

M45

ICD-10 Finland

Ankylosing spondylitis

5.8

22.0

J01DB01

ATC

cefalexin; oral

1.8

21.8

1611

14050

K83.1

ICD-10 Finland

Obstruction of bile duct

4.8

21.8

104

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.6

21.8

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

25.3

21.8

WX002

NOMESCO Finland

Sedation and analgesia

1.8

21.8

367

2197

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

21.7

181

842

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

8.8

21.6

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.2

21.5

276

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

21.4

319

1836

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

21.4

206

1016

K74.0

ICD-10 Finland

Hepatic fibrosis

26.7

21.4

H04AA01

ATC

glucagon; nasal, parenteral

26.7

21.4

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

21.1

349

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

8.5

21.0

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

21.0

573

3915

M05BA04

ATC

alendronic acid; oral

2.3

21.0

161

723

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.6

21.0

205

JN4AD

NOMESCO Finland

Body CT examination

2.0

20.9

234

1221

K76.89

ICD-10 Finland

Other specified diseases of liver

18.0

20.9

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

+∞

20.9

109

Kela drug reimbursment

Multiple sclerosis

+∞

20.9

K70.0

ICD-10 Finland

Alcoholic fatty liver

7.4

20.8

L40.5

ICD-10 Finland

Arthropathic psoriasis

77.6

20.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

20.7

407

2546

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.8

20.7

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.2

20.7

E0000UV, ,

ATC

1.6

20.6

770

5672

B16.9

ICD-10 Finland

Acute hepatitis B without delta-agent and without hepatic coma

212.1

20.6

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.7

20.5

112

428

Z2446

NOMESCO Finland

Social worker

2.4

20.5

142

609

A41.9

ICD-10 Finland

Sepsis, unspecified

3.4

20.5

228

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

20.2

774

5727

N05BA04

ATC

oxazepam; oral

1.7

20.2

499

3319

K51

ICD-10 Finland

Ulcerative colitis

48.5

20.2

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

20.2

421

2676

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

20.1

240

1282

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

19.9

305

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.8

19.7

357

M35.1

ICD-10 Finland

Other overlap syndromes

201.9

19.6

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

201.9

19.6

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

19.6

195

974

F10.24

ICD-10 Finland

Alcohol depence active use

4.2

19.4

123

R53

ICD-10 Finland

Malaise and fatigue

1.7

19.4

475

3149

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

19.3

650

4658

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

46.5

19.2

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

19.1

171

819

A07AA11

ATC

rifaximin; oral

22.8

19.1

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

20.3

19.1

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.9

19.0

147

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

18.9

359

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

18.8

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

7.1

18.7

AA1AD

NOMESCO Finland

CT of head and brain

1.6

18.7

516

3521

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

101.0

18.6

C07AB07

ATC

bisoprolol; oral

1.5

18.4

839

6415

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.8

18.4

358

D05AX52

ATC

calcipotriol, combinations; topical

3.2

18.3

239

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.3

18.3

138

615

N07BB01

ATC

disulfiram; oral

2.7

18.3

377

P19

ICPC

Drug abuse

6.0

18.3

D94

ICPC

Chronic enteritis/ulcerative colitis

25.3

18.2

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.8

17.8

B17.8

ICD-10 Finland

Other specified acute viral hepatitis

67.2

17.7

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

17.7

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

17.7

RD210, ,

NOMESCO Finland

5.1

17.6

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.1

17.6

250

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

5.5

17.6

D07AC01

ATC

betamethasone; topical

1.5

17.4

655

4788

L04AB01

ATC

etanercept; parenteral

17.1

17.4

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

17.4

135

609

UJK12

NOMESCO Finland

Peroral cholangioscopy

42.4

17.3

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.0

17.3

253

N05BA12

ATC

alprazolam; oral

2.0

17.1

200

1058

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

17.1

693

5146

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

50.5

17.0

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

6.9

17.0

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.1

17.0

118

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

16.9

108

446

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

16.8

208

1122

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

16.7

179

917

K30

ICD-10 Finland

Functional dyspepsia

1.9

16.7

233

1308

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

35.3

16.7

A02BA02

ATC

ranitidine; systemic

1.7

16.6

329

2050

A10AE06

ATC

insulin degludec; parenteral

3.9

16.6

129

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.0

16.5

116

E10

ICD-10 Finland

Type 1 diabetes mellitus

27.8

16.5

S97

ICPC

Chronic ulcer skin

2.5

16.4

109

459

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

16.4

328

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

16.2

319

1983

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

16.2

285

1716

JKA20

NOMESCO Finland

Cholecystectomy

3.5

16.2

164

N03AX12

ATC

[U] gabapentin; oral

1.8

16.2

288

1740

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

12.9

16.2

N02AA05

ATC

oxycodone; systemic

1.7

16.1

318

1980

R03AC02

ATC

salbutamol; inhalant

1.5

16.0

1026

8331

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

15.9

179

933

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

15.9

416

2785

K85

ICD-10 Finland

Acute pancreatitis

4.5

15.9

R42

ICD-10 Finland

Dizziness and giddiness

1.6

15.9

411

2746

R4110

NOMESCO Finland

Physiotherapy

1.6

15.9

517

3647

N05AF03

ATC

chlorprothixene; systemic

3.3

15.8

187

R60.0

ICD-10 Finland

Localized oedema

1.9

15.7

225

1274

K73.89

ICD-10 Finland

Other long-term hepatitis, not classified differently

+∞

15.6

L04AB02

ATC

infliximab; parenteral

+∞

15.6

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

15.6

P15

ICPC

Chronic alcohol abuse

2.9

15.6

257

N06AX11

ATC

mirtazapine; oral

1.5

15.6

632

4673

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.6

15.5

140

M01CB01

ATC

sodium aurothiomalate; parenteral

161.2

15.5

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

6.3

15.5

XW000

NOMESCO Finland

Bone marrow biopsy

2.7

15.4

304

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.7

15.4

333

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

15.4

405

2715

N03AX16

ATC

[U] pregabalin

1.6

15.3

401

2684

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

15.2

201

1109

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

6.1

15.1

K72.1

ICD-10 Finland

Chronic hepatic failure

23.6

15.1

P16

ICPC

Acute alcohol abuse

3.7

15.0

129

R10.0

ICD-10 Finland

Acute abdomen

2.8

15.0

263

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

14.9

297

1850

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

14.9

153

772

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

14.8

152

766

H02AB04

ATC

methylprednisolone; systemic

1.8

14.8

248

1471

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.4

14.8

103

443

B01AB05

ATC

enoxaparin; parenteral

1.5

14.8

548

3968

L28

ICPC

Limited function/disability (L)

1.7

14.8

321

2048

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.8

14.7

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.8

14.7

117

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

18.5

14.7

SPAT1255

SPAT

Intravenous administration of medicine

2.2

14.7

126

593

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.5

14.6

390

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

+∞

14.6

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

+∞

14.6

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

80.7

14.6

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.3

14.6

M04AA01

ATC

allopurinol; systemic

1.9

14.6

198

1101

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

14.3

14.5

JN4BD

NOMESCO Finland

Extensive body CT

1.9

14.5

186

1014

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

14.5

209

1184

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

14.4

117

538

N06AB10

ATC

escitalopram; oral

1.6

14.3

387

2605

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.9

14.3

110

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

13.5

14.2

J01EA01

ATC

trimethoprim; systemic

1.6

14.2

451

3152

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.5

14.2

347

WX872

NOMESCO Finland

Intensive care

2.4

14.1

396

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

14.1

1373

11952

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

12.0

14.1

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

14.0

230

1357

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

15.9

13.9

A46

ICD-10 Finland

Erysipelas

1.8

13.9

239

1428

N05CF02

ATC

zolpidem; oral

1.6

13.9

324

2103

TGC00

NOMESCO Finland

Bronchial lavation

3.4

13.9

146

K81.9

ICD-10 Finland

Cholecystitis, unspecified

5.1

13.8

M07.3

ICD-10 Finland

Other psoriatic arthropathies

53.7

13.8

U07

ICPC

Urine symptom/complaint other

2.0

13.8

161

850

M79.6

ICD-10 Finland

Pain in limb

1.4

13.8

818

6482

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

13.8

455

3205

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

13.8

426

2957

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.4

13.7

142

WVA20

NOMESCO Finland

Medicine administration

3.0

13.7

204

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

13.7

199

1131

H3603, E103,

ICD-10 Finland

+∞

13.6

K73.8

ICD-10 Finland

Other chronic hepatitis, not elsewhere classified

+∞

13.6

ZXA10

NOMESCO Finland

Bilateral

1.7

13.5

306

1972

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.1

13.5

190

R06AE07

ATC

cetirizine; oral

1.4

13.3

811

6446

M05BA07

ATC

risedronic acid; oral

3.1

13.3

186

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

3.2

13.2

166

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.4

13.2

384

E87.6

ICD-10 Finland

Hypokalaemia

2.6

13.1

294

K80.4

ICD-10 Finland

Calculus of bile duct with cholecystitis

4.8

13.1

F32

ICD-10 Finland

Depressive episode

2.2

13.1

105

481

R06.0

ICD-10 Finland

Dyspnoea

1.5

12.9

462

3305

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

12.9

102

464

B27.0

ICD-10 Finland

Gammaherpesviral mononucleosis

5.6

12.9

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

12.9

135

686

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.9

12.8

N05BA02

ATC

chlordiazepoxide; systemic

3.2

12.8

159

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

12.7

375

2571

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

12.7

498

3630

N06AX16

ATC

venlafaxine; oral

1.7

12.7

265

1669

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

12.7

489

3552

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

12.7

178

1000

SPAT1254

SPAT

Administration of medicine

1.7

12.6

239

1468

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

+∞

12.5

L03AX13

ATC

glatiramer acetate; parenteral

+∞

12.5

N06AB03

ATC

fluoxetine; oral

1.7

12.5

227

1376

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

12.5

144

757

A11CC03

ATC

alfacalcidol; systemic

3.5

12.5

126

N30.0

ICD-10 Finland

Acute cystitis

1.6

12.5

312

2056

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

9.4

12.5

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.4

12.5

369

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

130.8

12.4

4AA12, ,

NOMESCO Finland

130.8

12.4

K81.0

ICD-10 Finland

Acute cholecystitis

3.4

12.4

127

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

12.3

325

2169

R02

ICPC

Shortness of breath/dyspnoea

1.7

12.3

235

1445

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.8

12.3

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

12.3

220

1329

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

3.0

12.3

179

SPAT1263

SPAT

Sampling

1.4

12.2

710

5574

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

12.1

545

4076

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

12.1

148

794

Z71.8

ICD-10 Finland

Other specified counselling

1.4

12.1

633

4873

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.3

12.1

134

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

4.2

12.1

J01DA01

ATC

[U] cefalexin

1.4

12.0

1107

9398

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

12.0

214

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

12.0

951

7871

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.3

12.0

R52.9

ICD-10 Finland

Pain, unspecified

1.8

12.0

184

1063

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

12.0

302

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

11.9

732

5799

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.7

11.8

227

D07AD01

ATC

clobetasol; topical

1.6

11.8

275

1779

M25.5

ICD-10 Finland

Pain in joint

1.4

11.8

608

4661

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.7

11.8

102

B07.9

ICD-10 Finland

Verruca simplex

2.5

11.8

298

XX9XE

NOMESCO Finland

Other ultrasound examination

14.7

11.8

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

11.7

129

668

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.8

11.7

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.9

11.7

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

11.6

169

959

H20.1

ICD-10 Finland

Chronic iridocyclitis

65.3

11.6

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

11.6

246

1555

N18.8

ICD-10 Finland

Other chronic renal failure

3.7

11.5

ZX108

NOMESCO Finland

Inhalation

5.7

11.5

R4120

NOMESCO Finland

Occupational therapy

2.0

11.5

118

596

H3600, E103,

ICD-10 Finland

+∞

11.5

4AB02, ,

NOMESCO Finland

120.7

11.4

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

120.7

11.4

N05AA02

ATC

levomepromazine; systemic

2.4

11.4

327

J01AA02

ATC

doxycycline; systemic

1.4

11.4

1438

12831

J01MA14

ATC

moxifloxacin; systemic

1.9

11.4

156

869

C08CA01

ATC

amlodipine; oral

1.4

11.4

633

4914

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

11.4

102

489

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.6

11.4

100

N06AX26

ATC

vortioxetine; oral

1.9

11.3

140

754

D07AB08

ATC

desonide; topical

1.8

11.3

182

1065

A10BA02

ATC

metformin; oral

1.5

11.3

459

3361

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

9.7

11.2

N06AA09

ATC

amitriptyline; systemic

1.8

11.1

158

890

R51.80

ICD-10 Finland

Headache

1.6

11.1

288

1913

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

5.3

11.1

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

10.1

11.0

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

10.1

11.0

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

11.0

448

3279

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.4

11.0

117

K75.0

ICD-10 Finland

Abscess of liver

14.0

11.0

A03

ICPC

Fever

1.6

11.0

311

2108

A07AA09

ATC

vancomycin; oral

4.0

11.0

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

10.9

328

2251

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

3.6

10.9

B17.2

ICD-10 Finland

Acute hepatitis E

43.6

10.9

A10AD05

ATC

insulin aspart; parenteral

4.1

10.9

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

10.8

173

1011

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.1

10.8

149

S16

ICPC

Bruise/contusion

2.6

10.8

227

WW200

NOMESCO Finland

Immunization

2.9

10.7

171

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.7

10.7

N06AB05

ATC

paroxetine; oral

2.0

10.7

111

563

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

60.3

10.6

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

8.0

10.6

M01AH01

ATC

celecoxib; oral

1.6

10.5

296

2001

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

4.4

10.5

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

9.2

10.5

K02.1

ICD-10 Finland

Caries of dentine

1.4

10.5

1095

9395

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.6

10.5

C09AA05

ATC

ramipril; oral

1.5

10.5

389

2791

SPAT1260

SPAT

Consultation of another employee

1.6

10.5

284

1904

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

4.7

10.5

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

10.5

653

5157

K71.0

ICD-10 Finland

Toxic liver disease with cholestasis

110.6

10.4

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.7

10.4

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

+∞

10.4

L03AB07

ATC

interferon beta-1a; parenteral

+∞

10.4

WW500

NOMESCO Finland

Blood transfusion

2.4

10.4

316

L40.9

ICD-10 Finland

Psoriasis, unspecified

7.7

10.4

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.0

10.4

158

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.9

10.3

164

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.3

10.3

112

J02AC01

ATC

fluconazole; systemic

1.4

10.3

687

5485

E06.3

ICD-10 Finland

Autoimmune thyroiditis

23.5

10.2

K90.9

ICD-10 Finland

Intestinal malabsorption, unspecified

23.5

10.2

WX402

NOMESCO Finland

General anaesthesia

1.5

10.2

416

3038

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

10.2

114

593

K80.8

ICD-10 Finland

Other cholelithiasis

3.1

10.2

133

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

10.2

423

3103

A01

ICPC

Pain general/multiple sites

1.7

10.1

181

1092

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.3

10.1

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.6

10.1

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

10.0

232

1497

UKC02

NOMESCO Finland

Cystoscopy

1.6

10.0

227

1458

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

14.6

10.0

K29.4

ICD-10 Finland

Chronic atrophic gastritis

3.7

10.0

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

10.0

184

E000001, ,

ATC

1.5

9.9

320

2228

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

9.9

124

671

D07XC01

ATC

betamethasone; topical

1.7

9.9

177

1069

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

12.2

9.8

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

4.3

9.8

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

5.2

9.8

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

9.8

244

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

20.1

9.8

UJF02

NOMESCO Finland

Peroral enteroscopy

10.7

9.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

9.7

103

526

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

9.7

1001

8528

A28

ICPC

Limited function/disability NOS

1.6

9.7

272

1837

K92.1

ICD-10 Finland

Melaena

2.1

9.7

418

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

3.1

9.7

127

5714B

ICD-9 Finland

Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ACTIVA (HBSAG-)]

55.3

9.6

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.2

9.6

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

5.3

9.6

G47.3

ICD-10 Finland

Sleep apnoea

1.5

9.6

385

2799

F61.0

ICD-10 Finland

Mixed personality disorders

3.5

9.6

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

7.8

9.6

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.0

9.6

105

543

D05BB02

ATC

acitretin; oral

4.0

9.6

TPH04, ,

SPAT

4.3

9.6

A02BX02

ATC

sucralfate; oral

2.4

9.6

259

WX882

NOMESCO Finland

High dependency care

2.7

9.6

188

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

9.6

174

1055

A07AA02

ATC

nystatin; oral

2.1

9.5

468

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

9.5

381

2770

H26.3

ICD-10 Finland

Drug-induced cataract

10.1

9.5

A12AA04

ATC

calcium carbonate; oral

4.0

9.5

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

9.5

168

1010

ZX120, ,

SPAT

3.8

9.5

J01FA06

ATC

roxithromycin; oral

1.4

9.4

684

5515

TQW80

NOMESCO Finland

Local dermatologic skincare

2.8

9.4

167

B01AA03

ATC

warfarin; systemic

1.6

9.4

259

1741

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

9.4

156

253, ,

Kela drug reimbursment

+∞

9.4

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

+∞

9.4

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

+∞

9.4

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

+∞

9.4

3042, ,

Kela drug reimbursment

+∞

9.4

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

+∞

9.4

N03AX09

ATC

lamotrigine; oral

2.1

9.4

410

R05

ICPC

Cough

1.4

9.4

448

3367

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

9.4

524

4048

WVA20, ,

SPAT

2.3

9.3

287

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

9.3

411

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

9.3

142

819

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

9.3

181

1118

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.7

9.3

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

9.3

201

1276

Z72.2

ICD-10 Finland

Drug use

7.3

9.2

K70.4

ICD-10 Finland

Alcoholic hepatic failure

7.3

9.2

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

4.2

9.2

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

9.2

277

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

9.2

105

552

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.3

9.1

310

S21

ICPC

Skin texture symptom/complaint

1.5

9.1

265

1805

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

8.3

9.1

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.2

9.1

111

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

9.1

9.0

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

9.0

450

3406

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

9.0

212

1375

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

9.0

229

1513

N06AX21

ATC

duloxetine; oral

1.6

9.0

202

1295

P99

ICPC

Psychological disorders other

2.4

9.0

255

WX419

NOMESCO Finland

Other general anesthesy

4.4

8.9

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.4

8.9

M81.4

ICD-10 Finland

Drug-induced osteoporosis

12.6

8.9

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

8.0

8.8

K08.3

ICD-10 Finland

Retained dental root

1.8

8.8

132

756

K85.8

ICD-10 Finland

Other acute pancreatitis

4.9

8.8

D86.0

ICD-10 Finland

Sarcoidosis of lung

4.0

8.8

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

8.8

202

1301

C07AG02

ATC

carvedilol; oral

2.0

8.8

469

N91.1

ICD-10 Finland

Secondary amenorrhoea

3.3

8.8

JN4CD

NOMESCO Finland

Very extensive body CT

2.3

8.7

283

WZC30

NOMESCO Finland

Teaching

1.5

8.7

275

1904

KH1AD

NOMESCO Finland

CT of urinary organs

2.3

8.7

271

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

8.7

342

S22.3

ICD-10 Finland

Fracture of rib

1.8

8.7

125

708

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

50.2

8.7

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

50.2

8.7

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

50.2

8.7

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

8.7

324

2322

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

8.7

114

628

E87.5

ICD-10 Finland

Hyperkalaemia

3.3

8.6

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.3

8.6

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

8.6

179

1124

J01CA04

ATC

amoxicillin; systemic

1.4

8.6

1522

13951

R07.3

ICD-10 Finland

Other chest pain

1.6

8.5

183

1158

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

8.5

469

3604

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.4

8.5

236

P01

ICPC

Feeling anxious/nervous/tense

1.6

8.5

222

1473

J01CA08

ATC

pivmecillinam; oral

1.3

8.5

702

5751

P06

ICPC

Sleep disturbance

1.6

8.5

228

1523

C09AA02

ATC

enalapril; systemic

1.5

8.5

278

1939

M10.9

ICD-10 Finland

Gout, unspecified

1.9

8.5

103

553

6BA02, ,

NOMESCO Finland

20.1

8.5

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

20.1

8.5

S18

ICPC

Laceration/cut

1.3

8.4

810

6782

K75.3

ICD-10 Finland

Granulomatous hepatitis, not elsewhere classified

90.4

8.4

K73.1

ICD-10 Finland

Chronic lobular hepatitis, not elsewhere classified

90.4

8.4

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

8.4

917

7816

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.7

8.4

166

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.6

8.4

L40.8

ICD-10 Finland

Other psoriasis

12.8

8.4

Z94.0

ICD-10 Finland

Kidney transplant status

4.9

8.4

RS220, ,

NOMESCO Finland

3.3

8.4

C07AB02

ATC

metoprolol; systemic

1.5

8.3

287

2022

L04AG05

ATC

vedolizumab; parenteral

+∞

8.3

M34.1

ICD-10 Finland

CR(E)ST syndrome

+∞

8.3

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

8.3

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

+∞

8.3

N05AB01

ATC

dixyrazine; systemic

3.6

8.3

R2110

NOMESCO Finland

Giving the first information

1.8

8.3

116

652

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

9.5

8.3

TJK01

NOMESCO Finland

Laparoscopic cholangiography

4.1

8.3

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.0

8.3

417

L40

ICD-10 Finland

Psoriasis

3.8

8.2

E66.8

ICD-10 Finland

Other obesity

1.9

8.2

100

537

SFA10

NOMESCO Finland

One-surface restoration

1.3

8.2

999

8635

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

8.2

377

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.0

8.2

118

J46

ICD-10 Finland

Status asthmaticus

2.5

8.2

204

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

8.2

524

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

7.6

8.2

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

8.1

433

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

4.8

8.1

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

8.1

180

1150

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

8.1

533

5739X

ICD-9 Finland

Other disorders of liver, Unspecified disorder of liver

33.5

8.1

K77.0*B25.1

ICD-10 Finland

Cytomegaloviral hepatitis

33.5

8.1

Z72.1

ICD-10 Finland

Alcohol use

3.3

8.1

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

11.7

8.1

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

6.8

8.1

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

9.0

8.0

A10BH01

ATC

sitagliptin; oral

1.7

8.0

148

901

SPAT1079

SPAT

Echocardiography

3.7

8.0

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

22.1

8.0

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

22.1

8.0

JAH00

NOMESCO Finland

Laparotomy

2.5

8.0

200

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

8.0

123

711

U02

ICPC

Urinary frequency/urgency

1.5

8.0

252

1745

A08

ICPC

Swelling

1.9

7.9

516

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.0

7.9

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.6

7.9

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.6

7.9

192

1255

D06

ICPC

Abdominal pain localized other

1.7

7.8

156

969

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

7.8

100

546

C05AA08

ATC

fluocortolone; rectal, topical

1.5

7.8

221

1493

K29.6

ICD-10 Finland

Other gastritis

3.2

7.8

R52.2

ICD-10 Finland

Other chronic pain

2.1

7.8

344

ZXE90

NOMESCO Finland

More than 22 hours

7.0

7.8

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

7.0

7.8

P03

ICPC

Feeling depressed

1.6

7.8

172

1098

R05

ICD-10 Finland

Cough

1.4

7.8

362

2700

N06AA12

ATC

doxepin; systemic

2.0

7.7

441

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

45.2

7.7

M81.8

ICD-10 Finland

Other osteoporosis

3.9

7.7

R1250

NOMESCO Finland

Evaluation of functional capability

2.6

7.7

174

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.4

7.7

S06.0

ICD-10 Finland

Concussion

1.6

7.7

183

1189

SPAT1227

SPAT

Substance abuse rehabilitation

5.9

7.7

B34.9

ICD-10 Finland

Viral infection, unspecified

2.4

7.7

229

F34.1

ICD-10 Finland

Dysthymia

2.2

7.6

287

P29

ICPC

Psychological sympt/compl other

1.7

7.6

131

783

R01AD09

ATC

mometasone; nasal

1.3

7.6

799

6749

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.4

7.5

S01BA04

ATC

prednisolone; ophthalmic

3.3

7.5

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.5

7.5

194

N06AX03

ATC

mianserin; oral

2.0

7.5

390

A01AB09

ATC

miconazole; local oral

1.7

7.5

130

778

K07

ICPC

Swollen ankles/oedema

2.0

7.5

370

OAB50, ,

SPAT

1.8

7.5

120

703

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

7.5

504

B81

ICPC

Anaemia vit B12/folate deficiency

2.6

7.5

159

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

7.4

330

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

7.4

1007

8784

SPAT1139

SPAT

Nutrition survey

2.3

7.4

226

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

2.5

7.4

189

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.6

7.4

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.8

7.4

115

667

OAA67, ,

SPAT

0.6

7.4

154

2365

N05AX12

ATC

aripiprazole; systemic

2.0

7.4

365

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

7.4

175

1136

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

7.4

483

3808

D01

ICPC

Abdominal pain/cramps general

1.5

7.3

216

1472

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

7.3

199

1332

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

7.3

819

6962

N05AF01

ATC

flupentixol; systemic

3.1

7.3

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

7.3

408

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

+∞

7.3

256, ,

Kela drug reimbursment

+∞

7.3

164

Kela drug reimbursment

Fingolimod

+∞

7.3

K50

ICD-10 Finland

Crohn disease [regional enteritis]

+∞

7.3

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

+∞

7.3

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

+∞

7.3

N20.0

ICD-10 Finland

Calculus of kidney

2.6

7.3

155

D01AE15

ATC

terbinafine; topical

1.8

7.3

114

663

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.5

7.3

N06AB06

ATC

sertraline; oral

1.6

7.3

193

1286

K59.0

ICD-10 Finland

Constipation

1.9

7.3

480

H03BB01

ATC

carbimazole; oral

2.3

7.3

235

TBW99

NOMESCO Finland

Other minor procedure in endocrine surgery

15.8

7.2

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.3

7.2

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

7.2

137

841

A04AA01

ATC

ondansetron; systemic, rectal

1.7

7.2

142

880

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

7.2

554

CKC12

NOMESCO Finland

Photocoagulation of retina

2.2

7.2

268

SPAT1265

SPAT

Breathalyser

3.7

7.2

K86.3

ICD-10 Finland

Pseudocyst of pancreas

7.3

7.2

F05.9

ICD-10 Finland

Delirium, unspecified

2.8

7.2

122

D02

ICPC

Abdominal pain epigastric

1.8

7.2

113

659

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

7.2

295

JN1DM

NOMESCO Finland

Upper part of abdomen very extensive MRI examination with 3 Tesla magnet

30.1

7.1

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

30.1

7.1

D51.0

ICD-10 Finland

Vitamin B12deficiency anaemia due to intrinsic factor deficiency

20.1

7.1

RS222, ,

NOMESCO Finland

3.5

7.1

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

7.1

586

4774

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

7.1

263

N02BF02

ATC

pregabalin; oral

1.7

7.1

117

691

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.3

7.1

231

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.0

7.1

101

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.4

7.1

206

SPAT1325

SPAT

Vaccination

1.3

7.1

506

4038

J01FA10

ATC

azithromycin; systemic

1.3

7.1

1016

8908

SPAT1240

SPAT

Therapeutic discussion

1.6

7.1

175

1148

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

7.1

456

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.9

7.0

449

JF1BD

NOMESCO Finland

Very extensive small bowel CT

8.8

7.0

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

8.8

7.0

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

10.1

7.0

SAA04

NOMESCO Finland

Special examination of mouth

1.9

7.0

443

RS221, ,

NOMESCO Finland

3.2

7.0

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.5

7.0

A29

ICPC

General symptom/complaint other

1.5

7.0

214

1471

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.8

7.0

124

N06AX05

ATC

trazodone; oral

2.4

7.0

189

B03XA02

ATC

darbepoetin alfa; parenteral

2.9

7.0

113

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

7.0

123

741

N03AX14

ATC

levetiracetam; systemic

2.3

7.0

214

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

6.9

285

2076

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

6.9

208

1424

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

6.9

116

689

K76.7

ICD-10 Finland

Hepatorenal syndrome

13.8

6.9

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

13.8

6.9

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

13.8

6.9

Z01.2

ICD-10 Finland

Dental examination

1.3

6.9

824

7051

L17

ICPC

Foot/toe symptom/complaint

1.3

6.9

508

4073

D11

ICPC

Diarrhoea

1.5

6.8

199

1353

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

6.8

390

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

6.8

454

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.2

6.8

261

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

6.8

146

925

SPAT1247

SPAT

Outpatient detoxication and monitoring

6.7

6.8

SBA10

NOMESCO Finland

Measurement of salivary flow rate

3.8

6.8

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

6.8

170

1118

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

6.8

236

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.6

6.8

120

Kela drug reimbursment

Hypogammaglobulinaemia

16.7

6.7

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

6.7

296

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

6.7

104

604

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

6.7

308

2288

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

3.2

6.7

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.6

6.7

150

N06AX17

ATC

milnacipran; oral

3.4

6.7

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.8

6.7

110

SFA20

NOMESCO Finland

Two-surface restoration

1.3

6.7

1055

9332

N86

ICPC

Multiple sclerosis

22.6

6.7

M01CB03

ATC

auranofin; oral

22.6

6.7

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

22.6

6.7

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

6.7

122

742

R04.2

ICD-10 Finland

Haemoptysis

2.2

6.7

244

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.9

6.6

105

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.2

6.6

238

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

6.6

175

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

6.6

175

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.1

6.6

E83.1

ICD-10 Finland

Disorders of iron metabolism

5.5

6.6

D09

ICPC

Nausea

1.9

6.6

409

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.6

6.6

N03AG01

ATC

valproic acid; systemic, rectal

1.8

6.6

533

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.5

6.6

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.2

6.6

239

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.4

6.6

B35.3

ICD-10 Finland

Tinea pedis

1.9

6.5

396

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

6.5

201

A04

ICPC

Weakness/tiredness general

1.5

6.5

248

1779

N05BE01

ATC

buspirone; oral

2.2

6.5

233

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

10.1

6.5

ZY010

NOMESCO Finland

Hospital outpatient

1.9

6.5

461

SPAT1216

SPAT

Assessment of functional ability

1.5

6.5

222

1560

N06AA06

ATC

trimipramine; systemic

2.4

6.5

189

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

6.5

307

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

6.5

307

D07AC13

ATC

mometasone; topical

1.3

6.5

460

3661

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

6.2

6.5

M79.7

ICD-10 Finland

Fibromyalgia

2.2

6.4

254

K11.2

ICD-10 Finland

Sialoadenitis

2.1

6.4

274

SPAT1104

SPAT

Monitoring of emergency patient

1.8

6.4

544

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

70.1

6.4

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

70.1

6.4

5719X

ICD-9 Finland

Chronic liver disease and cirrhosis, Unspecified chronic liver disease without mention of alcohol

70.1

6.4

L13.0

ICD-10 Finland

Dermatitis herpetiformis

70.1

6.4

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

6.4

384

2978

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.7

6.4

122

750

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

6.4

316

2375

PAW37

NOMESCO Finland

Biopsy of temporal artery

7.4

6.4

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

6.4

128

797

M01AB01

ATC

indometacin; systemic, rectal

1.7

6.4

104

613

N02AC04

ATC

dextropropoxyphene; oral

2.2

6.4

229

212

Kela drug reimbursment

Gout

2.9

6.3

M02AA07

ATC

piroxicam; topical

1.3

6.3

569

4681

E23.03

ICD-10 Finland

Lack of ACTH

11.1

6.3

D72

ICPC

Viral hepatitis

11.1

6.3

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

6.3

379

2942

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.7

6.3

114

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

9.3

6.3

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

6.3

190

1303

N05AH03

ATC

olanzapine; systemic

1.7

6.3

107

639

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

6.3

195

1345

0709X

ICD-9 Finland

Viral hepatitis, Unspecified viral hepatitis without mention of hepatic coma

18.1

6.3

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

18.1

6.3

E27.2

ICD-10 Finland

Addisonian crisis

+∞

6.3

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

+∞

6.3

K75.1

ICD-10 Finland

Phlebitis of portal vein

+∞

6.3

CL2L4

NOMESCO Finland

Wide-field fundus photography for diabetic retinopathy screening

+∞

6.3

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

+∞

6.3

H3601, E103,

ICD-10 Finland

+∞

6.3

353

Kela drug reimbursment

Cladribine and fingolimod

+∞

6.3

L04AA29

ATC

[U] tofacitinib

+∞

6.3

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

+∞

6.3

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

+∞

6.3

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

+∞

6.3

L04AA27

ATC

[U] fingolimod

+∞

6.3

N06AG02

ATC

moclobemide; oral

1.9

6.3

360

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.1

6.2

264

J01FA09

ATC

clarithromycin; systemic

1.3

6.2

520

4230

XQ845

NOMESCO Finland

Dermatoscopy

2.6

6.2

126

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

26.8

6.2

N05BB01

ATC

hydroxyzine; systemic

1.8

6.2

565

Z50.1

ICD-10 Finland

Other physical therapy

1.8

6.2

454

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.1

6.2

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

6.2

282

2092

R06.4

ICD-10 Finland

Hyperventilation

2.9

6.2

K29.7

ICD-10 Finland

Gastritis, unspecified

2.1

6.2

279

C08CA05

ATC

nifedipine; systemic

1.8

6.2

448

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

6.1

530

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.0

6.1

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

6.1

668

5628

C08CA02

ATC

felodipine; oral

1.6

6.1

124

776

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

6.1

501

E80.4

ICD-10 Finland

Gilbert syndrome

12.6

6.1

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

12.6

6.1

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.1

6.1

267

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

6.0

208

1464

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

6.0

221

1574

P76

ICPC

Depressive disorder

1.7

6.0

113

692

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

6.0

313

2371

T51.0

ICD-10 Finland

Toxic effect: Ethanol

6.7

6.0

N06AA04

ATC

clomipramine; systemic

2.7

6.0

111

N04BC05

ATC

pramipexole; oral

1.7

6.0

116

716

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

318

249

15.02

307.65

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

293

103

33.20

307.65

1.2

1.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

830

1543

8.53

307.65

5.4

2.1

0.20

0.22

g/l

7.99

792

1469

(3028026) IgM [Mass/volume] in Serum or Plasma

714

782

13.70

307.65

2.1

1.8

1.40

1.49

g/l

0.31

678

704

(3037522) Nuclear Ab [Titer] in Serum

844

1955

6.77

307.65

2.0

1.3

695.92

356.88

titre

6.98

309

333

(3005719) IgG [Mass/volume] in Serum or Plasma

872

992

14.89

307.65

7.3

2.6

12.06

10.62

g/l

9.70

849

897

(3007566) Smooth muscle Ab [Titer] in Serum

666

377

26.08

307.65

1.8

1.2

258.91

91.00

titre

3.08

129

(40768441) Liver Pathology biopsy report

331

39.93

307.65

1.6

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

334

239

16.60

307.65

1.2

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

296

251

13.68

299.27

4.8

5.7

734.56

567.56

iu/ml

0.20

(3017143) Hepatitis C virus Ab [Presence] in Serum

683

1718

5.54

266.61

1.7

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1323

5667

5.00

262.62

10.4

3.0

60.53

35.33

u/l

7.28

1287

5381

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

713

1905

5.28

258.38

6.7

2.7

17.30

7.74

umol/l

9.85

660

1683

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

274

261

12.02

256.20

1.3

299.45

251.58

u/ml

1.22

168

153

(3024980) IgG subclass 4 [Mass/volume] in Serum

251

221

12.86

246.82

2.1

1.7

0.79

0.81

g/l

0.04

199

180

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

247

216

12.92

243.87

2.4

2.9

335.81

3520.09

u/ml

0.76

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

190

104

20.10

241.64

1.6

1.1

276.78

110.00

titre

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

242

209

13.05

240.76

1.1

1.59

1.49

g/l

2.57

227

188

(3007164) IgA [Mass/volume] in Serum or Plasma

924

3202

4.53

237.76

2.1

1.4

2.70

2.36

g/l

5.38

734

1956

(3024561) Albumin [Mass/volume] in Serum or Plasma

1451

7051

4.93

233.98

11.4

4.5

35.13

36.00

g/l

7.23

1411

6615

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

269

284

10.80

233.77

1.2

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

779

2483

4.52

221.56

1.7

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

187

119

17.24

220.88

1.1

298.27

289.92

mg/l

0.49

179

110

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1598

8660

5.34

215.20

16.7

6.4

16.07

11.46

umol/l

11.43

1560

8268

(3048929) Epstein Barr virus Ab [Presence] in Serum

321

477

7.83

211.70

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

692

2086

4.56

210.40

2.9

2.3

26.89

23.03

6.02

668

1952

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

241

260

10.41

205.59

1.2

1.4

145.98

158.27

au/ml

0.58

(3023183) Ammonium ion [Moles/volume] in Plasma

265

332

9.06

201.56

4.8

3.1

37.87

37.46

umol/l

0.05

253

295

(42870588) Differential panel, method unspecified - Blood

1132

5028

3.91

195.63

12.7

4.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

711

2299

4.26

194.81

2.9

2.3

2.38

2.36

g/l

0.42

678

2125

(3022948) Iron [Moles/volume] in Serum or Plasma

732

2484

4.08

186.33

3.0

2.3

14.93

13.64

umol/l

3.43

704

2319

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

164

124

14.33

175.88

1.1

—

(3019069) Monocytes/Leukocytes in Blood

1368

7303

3.81

170.17

14.4

4.8

8.91

8.69

2.11

1331

6798

(3006504) Eosinophils/Leukocytes in Blood

1364

7289

3.79

168.92

14.3

4.7

2.87

2.82

0.34

1330

6774

(3022096) Basophils/Leukocytes in Blood

1363

7302

3.77

167.63

14.4

4.8

0.74

0.67

4.87

1327

6783

(3006315) Basophils [#/volume] in Blood

1436

7957

3.91

167.59

14.2

4.6

0.04

e9/l

0.23

1290

6697

(3032080) INR in Blood by Coagulation assay

1357

7258

3.75

167.12

16.6

13.3

1.18

1.22

inr

2.43

1198

5960

(3001604) Monocytes [#/volume] in Blood

1432

7935

3.89

166.77

14.2

4.6

0.57

e9/l

0.29

1291

6685

(3018010) Neutrophils/Leukocytes in Blood

1364

7371

3.72

164.09

14.1

4.6

56.85

56.87

0.02

1340

7008

(3002030) Lymphocytes/Leukocytes in Blood

1378

7529

3.72

162.15

14.3

4.7

28.16

28.15

0.01

1343

7105

(3019198) Lymphocytes [#/volume] in Blood

1445

8167

3.83

160.56

14.2

4.6

1.84

1.94

e9/l

1.50

1322

7092

(3013115) Eosinophils [#/volume] in Blood

1448

8259

3.78

157.12

14.6

4.8

0.18

0.19

e9/l

1.38

1326

7088

(3021879) Hepatitis B virus core Ab [Presence] in Serum

430

1122

4.62

153.12

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

952

4293

3.34

150.08

12.0

3.9

87.28

91.31

4.95

934

4212

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1050

5171

3.19

139.83

4.5

2.4

59.42

60.75

u/l

0.24

1004

4799

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

253

456

6.21

136.94

1.4

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

114

16.97

135.39

1.5

1205480.00

1020033.17

iu/ml

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1482

9182

3.42

127.75

17.7

8.3

3.89

4.09

e9/l

2.76

1349

7835

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1244

7296

2.89

111.72

4.0

2.2

76.47

77.19

nmol/l

0.41

1169

6629

(44816559) Phosphatidylethanol [Mass/volume] in Blood

291

707

4.65

111.55

2.0

1.8

0.31

0.33

mg/l

0.26

119

356

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

192

325

6.43

110.14

1.2

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1763

12697

4.47

109.40

23.2

6.9

101.85

78.95

u/l

31.05

1727

12013

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

162

231

7.55

109.14

1.6

1.4

0.57

0.10

iu/ml

0.74

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

797

3780

2.85

106.55

1.4

1.2

1.19

1.36

u/ml

0.24

187

1022

(3018418) pH of Serum or Plasma

921

4729

2.77

105.29

5.7

3.7

7.40

0.32

703

3321

(3023420) DNA double strand Ab [Units/volume] in Serum

227

491

5.09

99.79

2.2

1.3

6.92

6.11

iu/ml

0.15

111

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

463

1676

3.30

99.27

4.2

2.3

32.92

66.96

u/l

0.63

412

1420

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

190

362

5.70

96.20

2.0

1.1

24.78

6.80

iu/ml

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

147

222

7.07

93.82

1.3

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

232

546

4.68

91.93

1.7

1.1

4.22

3.60

iu/ml

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1274

8025

2.64

91.62

10.4

6.5

1.21

mmol/l

0.93

1121

6970

(3018677) aPTT in Platelet poor plasma by Coagulation assay

569

2426

2.89

90.63

2.5

2.1

30.33

29.34

2.87

555

2369

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1176

7166

2.57

90.09

9.1

6.0

1.21

mmol/l

1.04

1124

6628

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

207

470

4.80

85.55

1.7

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

499

2044

2.93

84.96

7.2

5.1

1.05

1.04

mmol/l

0.33

479

1885

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

515

2170

2.85

82.97

2.3

1.8

1.55

1.46

2.54

450

1933

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

108

134

8.47

81.64

1.2

1.1

50.39

63.27

u/l

0.79

114

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

760

3915

2.53

81.40

3.3

2.1

2.91

2.75

mg/l

1.01

678

3350

(3036481) Cortisol [Moles/volume] in Serum or Plasma

392

1443

3.14

80.30

2.7

2.1

345.35

385.49

nmol/l

3.93

376

1335

(4062490) Immunoglobulin typing, IgG

108

138

8.22

79.68

1.3

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

108

138

8.22

79.68

1.4

0.58

0.37

g/l

3.79

102

(3027135) IgG subclass 1 [Mass/volume] in Serum

108

138

8.22

79.68

1.4

9.92

6.70

g/l

4.98

103

(3028192) IgG subclass 2 [Mass/volume] in Serum

108

138

8.22

79.68

1.4

3.02

3.03

g/l

0.01

103

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1614

11821

2.95

79.55

9.2

3.1

107.71

45.84

u/l

34.25

1551

11172

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

433

1703

2.97

78.81

4.3

4.4

251.61

245.30

u/l

0.27

414

1619

(3048689) Calprotectin [Mass/mass] in Stool

455

1859

2.88

77.07

3.9

1.3

156.72

93.23

ug/g

3.43

401

1406

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

146

272

5.71

75.42

1.4

1.1

1.14

1.57

u/ml

0.34

(3023368) Bacteria identified in Blood by Culture

786

4242

2.41

74.58

6.0

4.1

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1626

12191

2.85

72.02

8.0

3.3

15.90

11.20

mm/h

25.02

1570

11394

(3021589) Normoblasts [#/volume] in Blood

1131

7219

2.32

71.64

22.4

9.3

0.00

e9/l

0.34

956

5779

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1199

7873

2.32

70.57

4.5

2.8

208.05

117.09

ug/l

4.82

1158

7384

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

16.86

70.42

4.5

1.7

0.58

0.62

mmol/l

2.16

(3020779) Urea [Moles/volume] in Serum or Plasma

360

1358

3.02

69.97

10.4

6.7

8.70

9.00

mmol/l

0.31

346

1310

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

10.79

69.50

1.3

1.1

105.31

77.81

u/l

1.18

(3012095) Magnesium [Moles/volume] in Serum or Plasma

567

2709

2.53

69.47

4.8

3.4

0.79

0.82

mmol/l

10.95

545

2566

(3010375) cycloSPORINE [Mass/volume] in Blood

14.43

69.20

30.8

28.5

122.20

130.09

ug/l

0.23

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

161

355

4.85

68.64

1.5

1.2

10.81

8.39

u/ml

0.15

(3017181) Myelocytes/Leukocytes in Blood

339

1254

3.05

68.09

6.2

3.7

0.57

0.97

3.06

137

345

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

160

354

4.83

67.92

1.5

1.2

8.11

2.29

u/ml

0.91

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

166

383

4.64

66.94

1.5

1.1

42.16

3.43

u/ml

—

(3002179) Metamyelocytes/Leukocytes in Blood

324

1185

3.07

66.27

6.1

3.6

0.40

0.74

2.81

126

322

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

10.64

66.16

1.3

1.1

26.35

17.70

u/l

0.59

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

284

976

3.23

64.50

2.1

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

607

3083

2.40

64.28

2.0

1.9

—

(3026782) Osmolality of Urine

590

2968

2.41

63.77

3.4

2.7

509.76

536.86

mosm/kgh2o

2.41

537

2564

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

217

633

3.73

63.68

4.2

3.6

351.87

2474.83

u/ml

0.74

192

548

(3013826) Glucose [Moles/volume] in Serum or Plasma

1359

9655

2.29

62.75

8.0

4.6

6.72

6.53

mmol/l

2.60

1308

9099

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

15.99

61.61

2.8

2.4

1968.02

5.03

ug/l

0.49

(3025159) Blasts/Leukocytes in Blood

319

1219

2.93

59.99

6.7

3.9

0.03

0.37

0.61

108

273

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

176

462

4.08

59.88

5.6

4.0

1.51

1.42

mg/l

0.68

167

430

(3037467) Urinalysis macro (dipstick) panel - Urine

1498

11210

2.37

59.24

5.9

4.0

—

2.74

—

(3021440) Promyelocytes/Leukocytes in Blood

317

1216

2.91

59.15

6.4

3.7

0.02

0.14

5.05

114

309

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

105

8.00

58.93

1.4

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

8.72

58.63

1.4

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

8.72

58.63

1.4

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

152

364

4.44

58.36

2.3

1.2

1.18

1.24

g/l

1.27

142

345

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

134

294

4.82

57.33

1.5

1.1

43.11

23.65

u/ml

0.71

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

148

352

4.46

57.31

2.3

1.2

0.21

0.25

g/l

5.81

138

334

(3030467) Casts [#/volume] in Urine by Automated count

769

4499

2.16

56.43

4.2

2.9

0.35

0.44

e6/l

0.67

590

3170

(40759836) Histone Ab [Presence] in Serum by Immunoblot

8.41

56.21

1.4

1.1

—

(3042936) Bacteria identified in Isolate by Culture

468

2231

2.44

56.11

2.5

1.9

—

(3027945) Reticulocytes/Erythrocytes in Blood

374

1604

2.64

56.09

3.4

2.4

1.99

1.73

3.16

349

1439

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

8.48

55.84

1.4

1.1

—

(36304419) Bacteria [Presence] in Urine

743

4305

2.16

55.75

4.1

2.8

—

0.00

estimate

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

8.73

55.62

1.4

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

8.08

55.12

1.4

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

198

597

3.57

55.08

1.9

1.5

1.36

1.55

g/l

1.94

173

518

(3031040) Bacteria [#/volume] in Urine by Automated count

1448

10827

2.25

55.05

5.8

4.3

476.95

2220.69

e6/l

1.59

136

(3002582) Erythrocytes [#/volume] in Urine

853

5241

2.10

54.58

4.3

3.0

28.13

73.77

e6/l

2.05

669

3860

(3018333) Ribosomal P Ab [Presence] in Serum

8.60

54.22

1.4

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

177

517

3.66

51.57

1.4

1.1

2.18

0.93

u/ml

—

(3000850) Epithelial cells [#/volume] in Urine

625

3474

2.17

51.34

3.2

2.4

8.10

6.34

e6/l

1.26

579

3126

(3018095) Leukocytes [#/volume] in Urine

935

6059

2.03

50.59

5.2

3.5

87.10

84.77

e6/l

0.03

691

4104

(40758558) Short blood count panel - Blood

803

5019

2.01

47.20

11.2

5.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

1193

8574

1.98

46.42

4.5

3.4

0.00

estimate

0.50

287

1703

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

134

6.18

45.96

2.4

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

1207

8726

1.98

45.96

4.6

3.4

0.00

0.19

estimate

0.54

268

1637

(3035350) Ketones [Presence] in Urine by Test strip

1201

8675

1.97

45.76

4.6

3.4

12.90

3.03

estimate

0.70

290

1734

(4035726) Immunohistochemistry procedure

336

1502

2.49

45.53

1.5

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

16.82

45.36

1.7

1.4

11.24

9.35

ug/l

0.92

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

8.14

45.32

1.7

1.5

5.11

5.03

u/l

0.01

(3023520) Reticulocytes [#/volume] in Blood

289

1215

2.61

44.47

2.9

2.3

75.43

69.18

e9/l

1.63

221

899

(40760892) CBC W Ordered Manual Differential panel - Blood

603

3471

2.06

43.97

8.6

3.4

—

(3035715) Granulocytes [#/volume] in Blood

181

5.22

43.56

4.8

2.7

3.93

4.41

e9/l

1.11

181

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

121

6.31

43.54

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

487

2597

2.16

43.40

2.1

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

277

1163

2.61

42.65

2.4

2.9

67.08

66.92

g/l

0.10

257

1058

(3017732) Neutrophils [#/volume] in Blood

374

1803

2.32

42.57

4.0

3.0

4.74

4.95

e9/l

0.15

347

1558

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

10.00

41.06

1.3

1.1

—

(3022145) Colonoscopy Study observation

350

1683

2.31

39.87

1.8

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

836

5540

1.88

39.33

3.4

2.3

—

(36660697) Celiac disease serology panel - Serum

293

1313

2.44

39.12

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

383

1935

2.21

38.64

2.0

1.7

—

(3012544) pH of Venous blood

331

1574

2.32

38.62

4.4

3.5

7.38

0.78

197

853

(3021960) Folate [Moles/volume] in Serum or Plasma

703

4425

1.91

38.62

1.9

1.6

19.84

20.29

nmol/l

0.34

629

3729

(40768797) Stomach Pathology biopsy report

430

2275

2.14

38.59

1.3

1.2

—

(3002032) Base excess in Venous blood by calculation

322

1515

2.34

38.50

4.5

3.5

1.38

1.89

mmol/l

1.62

278

1310

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

170

5.05

38.42

1.3

1.1

58.50

6.14

u/ml

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

368

1842

2.22

37.93

2.0

1.7

—

(3042733) HLA Ab [Presence] in Serum

10.72

36.72

2.2

4.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

7.49

36.13

1.0

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

323

1563

2.27

35.99

4.6

3.4

5.70

5.82

kpa

1.30

312

1517

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

173

625

2.94

35.34

2.0

44.80

39.84

u/l

1.95

162

547

(3052851) Hemolysis interference index of Serum or Plasma

128

392

3.42

34.51

3.9

3.4

1.63

2.17

index

0.65

221

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

993

7131

1.79

34.41

2.5

2.0

98.87

97.01

pmol/l

0.54

556

3669

(3026008) Bacteria identified in Urine by Culture

739

4868

1.83

34.19

3.6

3.0

—

(3035933) Granulocytes/Leukocytes in Blood

101

265

3.96

34.19

4.7

2.6

56.94

58.74

0.63

101

265

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

466

2657

1.99

33.56

3.6

2.7

2.82

2.77

e6/l

0.03

233

1238

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

7.36

33.56

3.2

3.4

1647.92

853.63

u/ml

1.09

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1079

7982

1.77

33.36

3.7

2.7

—

estimate

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

746

4978

1.80

32.71

2.6

2.0

185.27

248.41

u/l

1.16

715

4725

(3026493) Urate [Moles/volume] in Serum or Plasma

644

4115

1.84

32.57

3.7

2.5

341.24

336.84

umol/l

0.46

575

3646

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

487

2854

1.94

32.20

3.5

2.6

1.21

1.11

e6/l

0.13

254

1430

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

340

1761

2.12

31.69

4.3

4.5

5.90

25.25

ug/l

2.58

274

1414

(3015736) pH of Urine

954

6900

1.74

31.14

4.0

3.0

6.24

6.20

0.44

502

3892

(3000570) Elastase.pancreatic [Mass/mass] in Stool

133

448

3.11

30.67

1.7

1.4

252.66

309.27

ug/g

2.15

250

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

6.81

30.65

1.3

3.5

37.75

154.44

umol/l

2.65

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

7.35

30.15

1.0

1.2

1077.78

1050.00

titre

—

(3000991) Gas panel - Venous blood

285

1424

2.17

28.97

11.9

8.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

245

1165

2.26

28.10

4.2

3.4

88.28

82.13

ng/l

0.59

216

1002

(3015377) Calcium [Moles/volume] in Serum or Plasma

816

5786

1.70

27.59

3.6

3.5

2.34

2.36

mmol/l

3.60

766

5278

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

135

492

2.87

27.05

3.9

2.6

2.94

3.58

g/l

6.18

127

471

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

508

3169

1.81

26.92

4.6

3.5

383.94

418.67

ng/l

0.08

375

2346

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

115

386

3.10

26.66

1.4

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

213

3.87

26.54

3.3

2.5

14.36

5.80

umol/l

2.76

146

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

631

4208

1.73

26.47

3.5

2.3

—

(3009508) Creatinine [Moles/volume] in Urine

776

5481

1.68

26.28

4.1

3.1

7.03

7.74

mmol/l

4.47

654

4646

(3019309) Folate [Moles/volume] in Red Blood Cells

396

2305

1.90

26.09

1.7

1161.89

1151.05

nmol/l

0.08

323

1736

(3044007) Cell count panel - Peritoneal fluid

7.15

25.47

2.1

1.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

142

4.47

25.11

1.1

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

5.98

24.83

1.1

100.38

87.45

u/l

0.49

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

112

386

3.02

24.80

2.2

2.1

11.88

12.18

mg/l

0.12

106

353

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

443

2712

1.82

24.71

1.4

1.2

10.69

2.54

u/ml

1.60

145

1047

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

5.90

24.50

1.1

25.27

28.85

u/l

0.20

(3024471) HLA-A [Type]

7.97

24.30

1.0

—

(3024932) HLA-DR beta [Type]

7.97

24.30

1.1

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

279

1481

2.03

23.91

10.3

7.5

1.47

1.32

mmol/l

1.07

272

1454

(3014051) Protein [Presence] in Urine by Test strip

686

4782

1.66

23.87

3.3

2.7

0.04

0.03

—

110

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1519

12921

1.75

23.86

5.4

3.1

14.89

14.50

pmol/l

8.15

1422

11865

(3007853) Bacteria identified in Skin by Aerobe culture

330

1866

1.92

23.54

1.9

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

6.90

23.38

1.8

1.5

8.59

12.39

g/l

1.55

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

306

3.17

22.95

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

157

4.11

22.89

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1841

16747

2.37

22.68

31.3

13.0

19.86

24.83

mg/l

12.43

1708

13386

(3023487) Leukocytes [#/volume] in Peritoneal fluid

6.01

22.18

2.8

2.1

368.45

804.84

e6/l

1.07

(3000494) Fungus identified in Specimen by Culture

337

1960

1.87

21.93

1.7

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

196

939

2.21

21.90

1.7

—

(3003181) Sodium [Moles/volume] in Urine

273

3.25

21.89

1.7

1.4

51.88

60.53

mmol/l

1.37

222

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

111

409

2.82

21.78

2.2

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

102

359

2.94

21.77

4.9

3.6

58.43

1173.29

u/ml

0.91

330

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

575

2.52

21.69

1.7

2.6

7.53

7.23

g/l

1.08

129

519

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

575

2.52

21.69

1.7

2.6

4.22

4.21

g/l

0.05

128

519

(3019977) pH of Arterial blood

320

1841

1.88

21.52

10.2

7.6

7.42

7.41

1.65

176

946

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

138

575

2.50

21.21

1.7

2.6

3.74

3.75

g/l

0.02

128

519

(3041096) Erythrocytes [Presence] in Urine by Automated

662

4684

1.62

21.13

4.1

2.9

0.23

estimate

0.00

235

1326

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

319

1847

1.87

20.99

10.2

7.5

4.92

5.13

kpa

3.32

304

1787

(3027801) Oxygen [Partial pressure] in Arterial blood

319

1848

1.87

20.95

10.2

7.5

11.97

12.74

kpa

2.05

305

1789

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

222

3.42

20.61

1.2

1.1

230.00

98.33

titre

0.93

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

810

6052

1.57

20.33

4.4

3.4

120.91

40.47

ng/l

0.52

571

3995

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

546

2.50

20.12

1.7

2.7

2.99

2.91

g/l

0.37

121

490

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

549

3756

1.64

19.84

2.3

1.8

1.58

1.11

mg/l

2.69

448

2887

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

633

4490

1.60

19.71

3.6

3.0

1633.75

1146.21

ng/l

0.71

548

3802

(3024354) Oxygen [Partial pressure] in Venous blood

245

1329

1.96

19.57

3.9

3.1

4.80

4.51

kpa

1.21

235

1289

(3003396) Base excess in Arterial blood by calculation

311

1827

1.83

19.44

10.5

7.5

0.47

0.89

mmol/l

0.68

250

1524

(37208534) Antinuclear antibody arbitrary concentration in serum

6.75

19.15

1.3

1.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

274

1554

1.89

19.13

11.4

8.2

117.00

122.43

g/l

4.01

265

1519

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

5.21

19.13

3.0

1.5

25.38

30.13

umol/l

2.39

(3016502) Oxygen saturation in Arterial blood

286

1645

1.86

19.11

11.1

7.8

96.01

95.74

0.37

273

1594

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

6.08

19.06

2.8

2.0

926.65

33782.06

e6/l

0.54

(3029937) Albumin [Presence] in Urine by Test strip

645

4631

1.58

18.91

4.8

3.5

0.01

estimate

0.07

271

1591

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

223

1189

1.99

18.69

5.3

3.5

1.22

1.23

mmol/l

1.42

208

1031

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

110

437

2.61

18.66

1.7

2.5

0.00

0.01

g/l

1.01

395

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

853

6538

1.53

18.58

4.6

3.3

2.14

0.11

estimate

0.47

237

1375

(3013005) Retinol [Moles/volume] in Serum or Plasma

5.45

18.56

3.3

1.5

1.69

1.89

umol/l

0.84

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

275

1577

1.86

18.52

4.4

3.2

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1608

14208

1.69

18.41

39.0

16.4

14.00

13.51

32.59

1601

14006

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

452

2993

1.66

18.38

1.4

1.3

29.62

20.13

iu/ml

1.28

153

808

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

44.43

18.25

2.0

5.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

131

572

2.38

18.18

2.3

1.9

1.96

1.55

ug/l

0.23

120

510

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

120

505

2.46

18.05

1.9

2.5

0.40

1.28

g/l

2.42

104

437

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

111

459

2.50

17.34

2.6

3.3

0.29

0.37

iu/ml

1.53

251

(3020682) Albumin/Creatinine [Ratio] in Urine

686

5091

1.53

16.93

4.7

3.7

13.83

7.39

mg/mmol

1.41

411

3098

(3000093) Morphology [Interpretation] in Blood Narrative

119

4.02

16.77

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

116

498

2.41

16.72

1.7

2.6

12.80

10.22

g/l

3.53

105

439

(3012516) Albumin [Mass/volume] in Urine

677

5022

1.53

16.69

3.9

3.1

74.40

43.59

mg/l

1.42

429

3128

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

+∞

16.69

1.7

0.0

2.76

—

mg/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1843

17076

2.11

16.66

32.4

15.9

139.16

139.77

mmol/l

19.34

1834

16730

(40768804) Tissue Pathology biopsy report

879

6887

1.50

16.66

2.2

2.1

—

(3037756) Immunofixation for Serum or Plasma

277

2.89

16.42

1.4

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

103

422

2.52

16.41

1.7

2.5

0.00

g/l

-0.00

372

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

167

840

2.08

16.40

4.1

3.2

4.43

4.56

pmol/l

0.88

157

765

(3002331) Protein [Mass/volume] in Peritoneal fluid

6.57

16.21

1.4

16.29

26.77

g/l

1.34

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1718

15605

1.75

15.97

6.7

4.1

1.87

1.86

mu/l

0.20

1640

14461

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

114

496

2.38

15.95

3.0

2.6

214.56

183.14

2.84

108

472

(3009343) pH of Capillary blood

183

962

1.99

15.91

4.5

3.6

7.42

0.43

155

804

(3023103) Potassium [Moles/volume] in Serum or Plasma

1843

17117

2.07

15.89

32.6

16.0

3.93

3.96

mmol/l

3.96

1834

16728

(3003327) Ova and parasites identified in Stool by Light microscopy

127

583

2.26

15.70

1.8

—

(3036489) Thrombin time

134

633

2.20

15.45

2.7

2.2

21.68

20.77

1.52

125

569

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

185

988

1.96

15.37

4.6

3.6

5.18

5.16

kpa

0.13

178

946

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

461

3192

1.58

15.26

1.8

1.6

10400466.08

39665234.25

pmol/l

1.27

375

2685

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

394

2.51

15.25

1.8

2.5

0.00

g/l

-0.00

371

(3029075) Extractable nuclear Ab panel - Serum

4.47

15.21

1.1

1.0

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

222

1269

1.84

14.98

3.6

2.4

65.22

70.09

ml/min/173m2

0.86

518

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

176

937

1.96

14.74

12.0

9.9

15.73

16.08

0.81

167

903

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

419

2.43

14.74

1.6

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

163

850

2.00

14.49

4.4

3.5

2.14

1.83

mmol/l

0.43

123

637

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

404

2.45

14.47

1.9

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

133

3.60

14.37

2.1

1.5

1.02

1.36

promille

0.68

101

(3045414) Leukocytes [Presence] in Urine

244

1454

1.77

14.33

2.3

2.0

0.02

0.00

estimate

0.49

300

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

106

3.93

14.25

1.9

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

164

3.29

14.13

1.3

1.2

—

(40761536) Microorganisms panel - Urine sediment

214

1236

1.82

13.94

5.0

3.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

104

464

2.31

13.77

2.0

3.8

51.81

64.22

mg/l

0.33

402

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.31

13.39

1.6

2.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

103

466

2.28

13.20

2.0

3.7

39.01

75.42

mg/l

0.81

404

(3017704) Immunofixation for Urine

4.81

13.08

1.2

2.0

—

(3012501) Base excess in Blood by calculation

268

2.67

12.84

5.5

3.9

2.64

2.52

mmol/l

0.12

171

(3022621) pH of Urine by Test strip

219

1305

1.76

12.82

2.9

2.3

6.07

6.09

0.12

161

873

(3037121) Protein [Mass/volume] in Urine

111

526

2.18

12.72

3.9

3.3

297.00

286.66

mg/l

0.05

225

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

308

2.53

12.44

1.7

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

410

2.30

12.23

2.0

3.5

1.87

3.89

ratio

0.82

229

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1746

16171

1.66

12.09

28.4

12.9

84.13

82.99

ml/min/173m2

1.39

1662

14806

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

113

551

2.11

12.05

2.7

2.2

537.70

818.86

ug/l

0.29

107

525

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.87

11.91

1.0

1.1

—

(3025941) Bacteria identified in Stool by Culture

156

858

1.89

11.85

1.4

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

269

2.58

11.72

2.1

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

166

937

1.84

11.63

1.3

1.1

152.66

82.23

u/ml

1.66

294

(3047181) Lactate [Moles/volume] in Blood

455

2.19

11.43

5.5

1.27

mmol/l

0.02

402

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

321

2.42

11.42

1.7

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

194

1160

1.75

11.20

3.8

2.9

257.77

177.36

ng/l

0.77

171

1050

(3008757) Leukocyte morphology finding [Identifier] in Blood

126

3.30

11.11

3.0

4.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

104

509

2.10

11.00

2.8

2.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

144

3.10

10.77

3.0

3.9

7.85

6.77

mmol/l

1.22

118

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

9.63

10.75

1.3

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

427

2.19

10.72

2.0

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

112

570

2.02

10.68

1.3

201.49

209.00

miu/ml

0.08

274

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

172

2.90

10.63

1.1

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.30

10.59

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

346

2.31

10.52

1.7

1.4

—

(1616796) Gas panel - Central venous blood

297

2.41

10.44

5.7

3.4

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

+∞

10.42

4.6

0.0

24.20

—

mg/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

+∞

10.42

4.4

0.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

4.20

10.36

1.1

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

4.20

10.36

1.1

1.3

—

(21494814) CD8 cells/Lymphocytes in Specimen

4.93

10.26

1.8

2.4

28.55

31.02

0.27

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

230

2.57

9.99

1.6

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

285

2.40

9.95

1.7

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

159

936

1.76

9.69

6.5

6.4

24.15

24.54

mmol/l

0.52

150

895

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

142

811

1.81

9.59

1.7

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

186

1149

1.68

9.53

1.5

1.3

153.20

214.98

u/ml

0.92

169

1064

(40768443) Skin Pathology biopsy report

120

653

1.89

9.45

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

3.66

9.27

1.7

1.2

7.17

5.74

u/l

0.45

(3022313) Gas panel - Capillary blood

125

694

1.85

9.25

4.6

3.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

439

3297

1.43

9.19

3.2

3.0

2.46

2.45

mmol/l

0.86

393

2951

(3045424) Erythrocytes [Presence] in Urine

125

696

1.85

9.17

2.3

2.0

0.00

1.10

estimate

0.50

229

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

183

2.66

8.97

2.1

2.3

32.04

32.19

0.07

183

(3019150) Specific gravity of Urine by Refractometry

497

3831

1.40

8.93

4.7

3.4

1.02

1.42

kg/l

0.50

343

2475

(3020717) Zinc [Moles/volume] in Serum or Plasma

3.49

8.93

1.6

1.3

15.23

28.63

umol/l

2.03

(3044927) Protein electrophoresis panel - Urine

128

3.01

8.90

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

145

2.87

8.82

4.6

3.4

20.93

12.83

index

1.52

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

380

2.10

8.42

2.2

1.7

4.27

2.81

iu/l

0.52

138

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

190

2.56

8.34

1.8

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

302

2.23

8.34

1.6

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

323

2.18

8.25

1.8

1.5

17568.33

11309.92

e6/l

0.45

224

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

14.53

8.20

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

311

2.19

8.18

4.0

2.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1869

17895

1.76

8.09

29.2

9.8

40.82

26.26

u/l

28.27

1857

17408

(3014007) Fractional oxyhemoglobin in Arterial blood

173

1099

1.63

7.96

14.9

9.4

93.99

93.94

0.03

173

1091

(3051651) Icteric interference index of Serum or Plasma

3.19

7.82

5.3

3.5

2.00

0.87

index

1.39

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

3.41

7.81

2.9

2.5

38.58

41.66

0.38

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

175

2.55

7.60

3.0

4.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

252

2.26

7.39

1.9

1.7

—

(3000330) Specific gravity of Urine by Test strip

128

767

1.71

7.37

3.6

3.2

1.02

ratio

0.14

113

698

(3000012) Reticulocyte production index

196

2.43

7.36

2.2

2.0

0.97

0.86

0.79

138

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

190

2.45

7.36

2.5

2.0

7968.00

2022.86

titre

—

(3026389) Candida sp identified in Specimen by Organism specific culture

203

2.40

7.30

1.5

1.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

128

2.77

7.13

1.8

1.4

53.23

66.08

0.88

(21494755) Public health laboratory ask at order entry panel

110

1819

0.58

7.13

1.3

—

(3042631) Mycobacterium sp identified in Specimen

200

2.38

7.06

2.2

2.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

435

1.92

7.04

1.2

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.24

6.98

2.4

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.24

6.98

2.4

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.24

6.98

2.4

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.24

6.98

2.4

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

234

2.26

6.89

1.3

1.2

5.48

5.60

u/ml

0.02

(4198724) Urine methamphetamine measurement

3.28

6.83

2.0

1.5

—

(3028433) Virus identified in Specimen by Culture

4.12

6.81

1.6

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

191

2.39

6.81

1.7

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

161

2.52

6.78

2.3

1.8

90.02

89.93

0.04

161

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

336

2.03

6.75

1.7

1.3

—

(3023419) Bacteria identified in Sputum by Culture

211

2.31

6.72

1.9

2.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.32

6.69

1.5

1.4

—

(21494434) Karyotype in Bone marrow

127

2.71

6.68

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

244

2.20

6.66

1.2

1.1

31.00

2.32

iu/ml

0.73

(3032773) Endomysium IgG Ab [Titer] in Serum

145

2.58

6.62

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

185

1247

1.53

6.62

2.1

2.3

7.64

7.43

ug/l

0.07

165

1116

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

115

690

1.71

6.61

5.4

4.5

1.91

1.54

1.51

107

650

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.27

6.56

1.5

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

123

2.71

6.51

2.1

1.2

117.79

109.51

pmol/l

0.18

123

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1869

18007

1.65

6.41

38.1

16.9

77.05

74.68

umol/l

2.08

1863

17787

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

316

2.03

6.37

1.9

1.7

0.72

0.91

nmol/l

1.54

280

(3014765) Yersinia sp identified in Stool by Organism specific culture

436

1.87

6.36

1.2

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

3.05

6.35

1.4

1.3

128.81

136.02

nmol/l

0.43

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.11

6.32

1.1

1.2

—

(3011985) Renin [Units/volume] in Plasma

218

2.23

6.25

3.1

1.3

47.89

52.30

mu/l

0.10

192

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

180

2.36

6.25

1.1

—

(3018572) Chloride [Moles/volume] in Blood

313

2.01

6.17

6.6

6.4

103.63

105.49

mmol/l

1.44

280

(3039000) Anion gap in Blood by calculation

313

2.01

6.17

6.6

6.4

11.07

11.38

mmol/l

0.24

280

(42529406) Shigella sp [Presence] in Stool by Culture

443

1.84

6.06

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

150

987

1.56

5.99

3.7

3.0

124.25

131.28

g/l

3.03

144

958

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

242

2.14

5.98

1.3

1.2

1.92

3.27

u/ml

0.63

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

122

766

1.63

5.93

2.6

2.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

7.26

5.92

1.8

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

311

1.99

5.92

5.0

2.9

7.23

8.56

pmol/l

0.67

311

(3004347) Hepatitis D virus Ab [Presence] in Serum

15.05

5.90

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

113

2.68

5.83

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

487

1.78

5.78

1.7

1.5

9.22

8.72

u/l

0.14

384

(44790048) Parainfluenza type 2 nucleic acid detection

213

2.19

5.74

1.8

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

213

2.19

5.74

1.8

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

213

2.19

5.74

1.8

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

213

2.19

5.74

1.8

1.3

—

(3008898) HLA-B27 [Presence]

520

1.74

5.66

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

128

825

1.59

5.60

3.6

2.8

1.31

1.26

0.24

128

820

(3019225) pH of Specimen

202

1441

1.45

5.48

5.5

4.1

7.35

0.04

171

1022

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

6.22

5.38

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

9.13

5.28

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

5.41

5.22

1.5

3.6

0.27

0.19

e9/l

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

319

1.91

5.20

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

319

1.91

5.20

1.4

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

102

635

1.64

5.16

5.5

4.7

0.90

0.87

0.34

595

(3011288) Drugs identified in Urine by Screen method Nominal

512

1.71

5.15

6.3

2.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

104

2.62

5.06

1.2

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

105

2.59

4.97

1.2

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

6.91

4.95

1.2

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

124

819

1.55

4.91

3.5

2.8

0.66

0.62

0.87

124

814

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1209

11074

1.23

4.88

3.3

3.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

9.03

4.78

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

120

2.44

4.72

2.1

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

161

1134

1.46

4.70

2.5

2.4

16.44

21.69

au/ml

0.63

132

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.73

4.68

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

589

1.63

4.67

3.6

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

827

7315

1.22

4.58

2.2

1.8

1.43

1.37

mmol/l

0.96

716

6256

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

135

2.32

4.53

2.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

135

2.32

4.53

2.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

135

2.32

4.53

2.3

1.6

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

10.03

4.52

1.0

45.75

61.75

u/l

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

148

1035

1.46

4.49

1.3

41.78

50.39

au/ml

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

111

2.45

4.47

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

2.54

4.47

1.2

1.1

222.65

279.35

mg/l

1.18

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

236

1.97

4.46

1.1

2.26

2.13

eliau/ml

—

124

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

399

3264

1.28

4.43

1.6

—

(4268621) Lupus anticoagulant assay

176

2.12

4.39

2.4

2.2

—

(3002256) Pathology report gross observation

301

2378

1.31

4.36

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

5.52

4.29

1.1

—

(4281824) Cell count and differential, peritoneal fluid

219

1.98

4.27

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

159

2178

0.71

4.26

1.9

2.0

3.48

3.50

ratio

0.07

116

1680

(3042517) Benzodiazepines panel - Urine

6.95

4.16

4.7

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1669

15958

1.29

4.09

7.9

5.6

39.57

38.29

mmol/mol

6.25

1611

14994

(3027974) Hepatitis B virus e Ag [Presence] in Serum

8.03

4.06

1.1

2.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.68

3.99

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1704

16349

1.30

3.97

5.9

4.8

6.03

5.83

mmol/l

6.95

1618

15121

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.83

3.96

2.8

2.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

342

1.75

3.95

3.3

2.2

122.09

129.65

g/l

1.93

265

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

365

1.72

3.94

1.3

1.7

477.26

1914.74

e6/l

0.92

286

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

358

1.73

3.92

1.2

1.6

7.77

41.43

e6/l

1.07

267

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

106

2.38

3.91

1.2

37.31

40.92

mg/l

0.26

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.27

3.91

1.0

1.3

—

(40768446) Kidney Pathology biopsy report

4.08

3.90

2.2

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

367

1.71

3.87

1.3

1.4

3.95

3.66

mmol/l

1.42

350

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

7.30

3.86

1.0

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

330

1.75

3.85

1.4

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

708

0.53

3.84

1.1

0.50

0.64

ratio

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

185

1386

1.37

3.83

2.5

2.3

13.28

13.22

nmol/l

0.03

160

1285

(3044290) Cell count panel - Cerebral spinal fluid

338

1.74

3.83

1.3

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

540

1.58

3.81

1.2

1.3

—

(3027008) Opiates [Presence] in Urine

110

751

1.49

3.80

3.4

1.9

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.49

3.80

1.1

10.76

0.12

nmol/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

8.78

3.77

1.1

2.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.65

3.73

1.1

—

(3016879) Cocaine [Presence] in Urine

102

689

1.51

3.71

3.6

2.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

649

1.52

3.70

1.9

1.6

263.63

289.09

mu/l

0.35

599

(3004716) Salmonella sp identified in Stool by Organism specific culture

117

814

1.46

3.69

1.4

—

(3028300) Cannabinoids [Presence] in Urine

110

756

1.48

3.69

3.5

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

109

748

1.48

3.68

3.5

1.9

—

(3027944) Amphetamines [Presence] in Urine

108

741

1.48

3.65

3.6

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

238

1869

1.31

3.60

2.3

2.0

—

(4195642) Thrombophilia screening test

241

1.84

3.58

1.2

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

171

1281

1.37

3.56

1.5

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.82

3.52

1.1

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

575

1.54

3.52

2.6

2.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

6.17

3.50

1.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

160

2.02

3.40

2.0

2.4

1.14

1.04

g/24h

0.09

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.67

3.39

2.9

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.67

3.39

2.9

2.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.02

3.36

8.4

19.1

5.31

5.25

mmol/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

477

1.57

3.35

1.1

3.01

4.12

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1664

15989

1.25

3.35

4.9

4.0

1.34

1.28

mmol/l

2.34

1565

14824

(4024509) Urine culture

107

747

1.46

3.34

2.4

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.33

3.34

1.2

1.1

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

4.36

3.31

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

102

2.27

3.29

3.2

2.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

8.59

3.26

1.2

1.0

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

458

1.57

3.22

2.3

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

3.35

3.22

1.1

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

755

0.59

3.19

1.1

1.52

1.53

g/l

0.13

755

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.81

3.18

1.1

1.3

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

120

1635

0.72

3.14

1.7

3.29

3.49

mmol/l

0.83

1134

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.42

3.14

1.4

1.5

—

(3034426) Prothrombin time (PT)

3.26

3.14

1.2

28.38

28.10

0.07

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.30

3.10

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

276

1.72

3.08

2.1

2.4

35.30

91.53

ug/min

0.95

159

(3019832) Treponema pallidum Ab [Presence] in Serum

218

1730

1.29

3.07

1.8

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

254

2057

1.27

3.05

2.4

2.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

160

1.95

3.05

2.8

1.7

—

(3003694) ABO and Rh group [Type] in Blood

581

5124

1.19

3.04

1.6

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.90

3.02

1.3

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

147

1.99

3.00

2.5

2.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

4.30

2.99

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.76

2.98

1.1

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

412

1.57

2.95

1.3

1.5

462.98

523.54

mg/l

0.91

389

(3012441) Differential panel - Pleural fluid

141

2.00

2.95

2.0

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

235

1.76

2.93

1.2

1.3

0.63

8.14

nmol/l

0.50

227

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.33

2.91

1.4

1.5

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

108

2.14

2.90

1.6

1.3

34.57

30.45

0.18

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.70

2.89

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.70

2.89

1.4

—

(3008295) Osmolality of Serum or Plasma

178

1.87

2.87

1.6

1.5

277.22

280.94

mosm/kgh2o

0.38

136

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

171

1.89

2.86

1.9

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

143

1.97

2.85

2.0

1.3

23881.31

67910.92

e6/l

0.59

(3045142) Bone marrow Pathology biopsy report

194

1.82

2.80

1.3

—

(3017569) Oxygen content in Arterial blood

2.23

2.80

1.8

14.62

16.65

1.72

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.46

2.79

1.8

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

674

1.43

2.77

1.6

1.7

11.01

13.96

u/ml

0.45

169

(3024522) Salmonella sp identified in Specimen by Organism specific culture

173

1.86

2.77

1.9

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

525

1.49

2.76

2.2

1.8

—

(1761868) Lipid panel - Serum or Plasma

632

7023

0.85

2.75

3.2

2.9

—

(3007463) Buprenorphine [Presence] in Urine

8.35

2.75

10.8

4.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

8.35

2.75

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

174

1.85

2.73

1.9

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

5.01

2.73

3.0

2.6

0.14

0.86

u/field

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.72

1.8

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

160

1.89

2.71

1.3

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.25

2.70

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

105

2.11

2.69

2.9

1.7

114.77

93.11

ng/l

0.50

105

(3023323) Follitropin [Units/volume] in Serum or Plasma

123

920

1.36

2.65

1.6

1.5

22.86

27.76

iu/l

1.10

107

779

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

191

1.79

2.63

5.9

3.4

4.26

4.70

nmol/l

0.12

186

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.47

2.62

2.5

2.8

24.65

19.33

ug/l

0.44

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

178

1.81

2.56

1.5

2.0

15.33

23.36

mg/l

0.86

(4027681) Cerebrospinal fluid IgG ratio and IgG index

2.23

2.54

1.4

1.2

0.51

ratio

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

164

1.84

2.53

2.0

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

611

1.43

2.52

2.2

2.3

6411.07

6098.14

u/l

0.03

249

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.33

2.48

2.6

2.1

—

(40768806) Pleura Pathology biopsy report

151

1.87

2.47

1.9

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

188

1.77

2.45

1.9

1.6

485.79

321.24

mu/l

0.51

152

(3000034) Microalbumin [Mass/volume] in Urine

123

1.96

2.45

4.0

2.8

152.79

28.87

mg/l

0.85

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

166

1.82

2.45

2.0

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.15

2.45

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.56

2.44

1.2

0.34

0.28

g/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.14

2.43

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

174

1.79

2.42

2.8

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.18

2.41

1.5

1.6

7.21

7.60

mmol/l

0.29

(3005988) Vibrio sp identified in Specimen by Organism specific culture

167

1.81

2.41

2.0

1.6

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.26

2.37

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

6.26

2.37

1.2

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.22

2.30

1.3

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

200

1.71

2.29

1.2

1.3

0.17

0.27

nmol/l

0.59

162

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.13

2.29

1.0

0.96

1.10

u/l

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

3.49

2.27

1.3

—

mmol/l

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

3.11

2.22

2.8

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.34

2.22

1.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

187

1.72

2.21

1.2

1.1

84.84

97.93

2.21

176

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

120

922

1.32

2.21

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

180

1.73

2.19

1.3

1.7

—

(4034850) Laboratory test

538

0.61

2.18

16.8

8.6

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

4.30

2.15

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.01

2.14

1.0

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

152

1.79

2.12

1.1

2.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

2.01

2.10

12.2

8.1

51.38

61.20

u/ml

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.46

2.10

1.0

1.2

—

(3023410) Appearance of Cerebral spinal fluid

175

1.73

2.10

1.2

1.9

—

(3033099) Centromere Ab [Titer] in Serum

3.21

2.09

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.91

2.07

1.1

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.71

2.07

1.2

1.9

21.97

14.48

umol/l

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.71

2.07

4.2

3.5

4.62

4.88

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.71

2.07

4.2

3.5

11.28

10.34

kpa

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1735

16914

1.20

2.04

6.0

4.8

4.58

4.72

mmol/l

6.59

1655

15924

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.01

2.04

2.3

2.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

263

1.57

2.01

1.1

1.12

3.50

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

271

1.56

2.01

1.3

1.2

23.17

35.66

u/l

0.66

231

(3008536) Aspergillus sp Ab [Presence] in Serum

2.82

2.00

2.8

2.1

—

(3049717) Cytology report of Urine Cyto stain

562

1.39

1.99

2.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.15

1.98

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.15

1.98

1.5

1.3

163.20

157.05

mmol/24h

0.07

(3045788) Cell count panel - Pleural fluid

141

1.78

1.97

2.1

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

112

1.88

1.96

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

202

1.64

1.96

1.2

1.3

—

nmol/l

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.97

1.93

1.4

1.0

6.10

6.57

mg/g

—

(3023199) Leukocytes [#/volume] in Pleural fluid

165

1.71

1.91

2.0

1.3

2423.25

1732.09

e6/l

0.40

108

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.25

1.91

3.2

3.5

0.69

1.51

1.37

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.54

1.84

1.2

4.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

2.13

1.82

1.1

1.5

—

68.38

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

271

1.52

1.79

1.1

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

2.17

1.77

1.2

1.1

5.56

11.24

u/ml

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

256

1.53

1.76

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

148

1.70

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.96

1.69

1.7

1.4

2122.25

387.84

u/l

0.46

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

310

1.46

1.64

1.4

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

335

1.44

1.64

4.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

488

1.36

1.63

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

214

1.55

1.60

1.2

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.91

1.59

1.1

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.01

1.58

1.3

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

144

1.67

1.57

1.1

1.2

14.07

15.87

u/ml

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

1.86

1.56

18.7

12.6

0.67

0.61

mmol/l

0.46

(4015189) Microbial culture of sputum

2.43

1.53

1.1

2.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

346

0.60

1.53

2.2

3.9

14.95

34.28

u/ml

3.49

338

(3052592) Norovirus Ag [Presence] in Stool

2.86

1.50

1.3

—

(3014271) Vancomycin [Susceptibility]

2.01

1.48

3.8

2.7

—

(40768793) Breast Pathology biopsy report

498

0.68

1.46

1.1

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

187

1.56

1.46

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

187

1.56

1.46

1.9

1.3

28.80

34.35

g/l

1.04

168

(3010144) Erythrocytes [#/volume] in Synovial fluid

117

1.72

1.45

1.4

1.2

44231.17

183699.45

e6/l

0.95

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.13

1.44

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

118

1.70

1.41

1.7

2.1

7.64

6.38

mmol/l

0.77

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.26

1.40

1.3

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.01

1.38

1.9

1.8

58.42

94.18

nmol/24h

1.28

(3025018) Bordetella pertussis Ab [Titer] in Serum

128

1.65

1.33

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

332

0.63

1.32

1.5

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

122

1010

1.22

1.32

2.7

1.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.81

1.31

1.9

2.4

47.93

52.37

umol/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

121

1.66

1.30

1.6

2.0

3.15

1.70

u/field

0.55

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.50

1.30

1.3

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

250

2822

0.87

1.29

2.9

3.0

0.56

0.74

ug/l

6.59

156

1720

(40757373) Influenza virus identified in Isolate

2.36

1.29

1.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.78

1.28

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.89

1.28

2.9

3.5

—

(3025130) Human papilloma virus identified in Specimen

285

1.41

1.28

1.9

2.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.05

1.27

2.2

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.23

1.24

1.0

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

220

1.46

1.23

1.3

22.49

24.33

u/l

0.11

178

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1715

16829

1.14

1.23

5.8

4.7

1.44

1.47

mmol/l

2.43

1625

15749

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.91

1.22

1.1

1.0

1379.33

1359.11

miu/ml

0.02

(44806071) Cardiolipin IgM antibody measurement

2.64

1.21

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.64

1.21

1.6

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.17

1.21

3.9

3.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1744

17137

1.15

1.20

6.5

5.4

2.66

2.79

mmol/l

7.44

1654

16061

(3022689) Creatine [Moles/volume] in Urine

2.01

1.16

1.7

1.2

6.28

8.15

mmol/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

335

1.35

1.14

1.0

1.1

18.47

14.27

au/ml

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.26

1.10

2.1

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.96

1.08

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.96

1.08

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.96

1.08

1.6

14.25

13.92

pmol/l

—

(3013637) Mi-2 Ab [Presence] in Serum

1.96

1.08

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.96

1.08

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.96

1.03

1.2

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.28

1.03

1.2

1.0

—

(3007461) Platelets [#/volume] in Blood

1879

18596

1.20

1.02

46.6

20.0

243.66

252.73

e9/l

6.46

1871

18205

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1879

18601

1.19

0.98

46.3

19.9

91.32

90.80

4.71

1874

18408

(3035941) MCH [Entitic mass]

1879

18602

1.19

0.98

46.2

19.9

30.42

30.27

2.59

1874

18409

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1879

18603

1.19

0.97

47.3

20.4

39.88

41.02

2.81

1874

18399

(3026361) Erythrocytes [#/volume] in Blood

1879

18603

1.19

0.97

46.4

20.0

4.42

4.52

e12/l

15.08

1868

18153

(3010813) Leukocytes [#/volume] in Blood

1879

18608

1.18

0.93

46.5

20.0

6.73

6.66

e9/l

0.50

1868

18150

(3000963) Hemoglobin [Mass/volume] in Blood

1879

18609

1.18

0.93

46.8

20.1

133.08

136.08

g/l

15.00

1874

18417

(40765089) Chromosome analysis panel - Blood by G-banded

1.82

0.92

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

325

2986

1.11

0.91

1.5

—

(40768795) Lymph node Pathology biopsy report

177

1.42

0.88

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

284

1.31

0.82

1.5

0.22

0.39

nmol/l

2.60

221

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.79

0.0

6.6

—

8.14

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.79

0.0

1.2

—

6.54

—

(3002619) Bacteria identified in Specimen by Culture

1.67

0.78

1.1

1.2

—

(4211845) Urine protein measurement

1.63

0.78

4.8

2.4

—

(3035880) pH of Pleural fluid

1.63

0.78

1.1

1.2

7.48

7.41

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

139

1228

1.14

0.78

2.7

2.1

—

(4146454) Self-monitoring of blood glucose

157

1.41

0.76

2.5

2.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

133

1.43

0.73

4.5

6.3

692.87

80.96

u/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

344

3684

0.92

0.73

3.9

4.1

22.05

20.96

0.59

147

1669

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.00

0.72

1.4

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

108

0.55

0.72

1.2

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

223

2040

1.10

0.71

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.58

0.71

1.3

1.8

40.89

40.28

g/l

—

(40765096) Chromosome analysis panel by Banding

1.55

0.69

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

446

1.22

0.69

1.3

1.2

—

(3006462) Nitrate [Presence] in Urine

1.60

0.68

4.1

2.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

483

0.80

0.66

1.5

57.48

59.87

ug/l

0.10

392

(40758292) HTLV I+II Ab panel - Serum

1.67

0.61

1.2

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

115

1024

1.13

0.61

4.1

3.8

34.09

82.59

u/ml

2.54

108

990

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.24

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.60

0.0

1.0

—

(40768800) Prostate Pathology biopsy report

299

0.77

0.59

1.3

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

114

1.41

0.59

1.2

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

162

0.68

0.58

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.48

0.57

1.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

160

1.32

0.53

3.2

1.8

—

(3024263) Appearance of Synovial fluid

1.45

0.53

1.7

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

447

0.82

0.52

1.5

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

810

0.87

0.52

1.5

1.6

1046.80

1007.99

mu/l

0.11

659

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

188

1.28

0.51

2.3

1.8

12.86

20.64

ug/l

4.35

183

(3050129) First trimester maternal screen panel - Serum or Plasma

531

0.84

0.50

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

146

1.30

0.47

1.0

1.1

0.04

0.68

u/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

665

0.87

0.47

2.0

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

134

1231

1.09

0.44

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

575

0.87

0.43

1.4

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

8.77

—

(3004451) EKG impression Narrative

1.34

0.39

1.3

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

707

0.89

0.39

2.1

1.7

4.08

4.56

mg/l

0.16

524

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

172

1837

0.93

0.39

11.1

6.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.35

0.38

1.0

1.2

13.92

9.29

mm/h

0.65

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.35

0.37

2.2

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

449

0.87

0.36

1.4

1.5

1.16

1.12

ratio

0.06

271

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

449

0.87

0.36

1.4

1.5

0.90

0.97

ratio

0.77

271

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

449

0.87

0.36

1.4

1.5

1.26

1.15

ratio

0.29

271

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

423

1.14

0.35

1.4

1.5

99.58

186.04

pmol/l

1.71

414

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.40

0.35

1.3

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.36

0.34

1.0

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.34

0.34

1.4

1.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

340

1.15

0.33

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

118

1.27

0.33

1.5

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

210

0.81

0.33

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.28

0.32

1.3

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.32

0.30

1.0

0.11

2.00

u/ml

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

100

0.70

0.30

1.3

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.30

0.30

1.1

78.39

54.30

u/ml

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

385

0.88

0.27

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

339

1.12

0.25

1.1

—

(3005033) Fetal Nuchal fold Thickness US

369

0.89

0.23

1.5

1.27

1.32

0.22

256

(3013166) Neutrophils/Leukocytes in Synovial fluid

1.28

0.23

1.0

1.2

53.80

57.49

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.24

0.23

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

305

1.12

0.21

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.19

0.21

1.2

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

1.12

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.15

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.07

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.16

0.21

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

470

1.09

0.20

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.23

0.20

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

322

0.90

0.19

1.1

2.30

2.50

u/ml

0.08

165

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

121

0.83

0.18

1.5

1.6

7.99

7.95

mmol/l

—

115

(3020650) Glucose [Presence] in Urine

1.11

0.17

1.9

1.4

0.00

0.05

estimate

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

467

4586

1.02

0.16

4.8

5.0

6.36

2.30

ug/l

0.62

425

4174

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

244

1.11

0.16

1.4

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

121

1.16

0.15

1.6

77.00

77.19

umol/l

0.01

121

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.11

0.15

1.1

1.4

35.03

39.46

nmol/l

—

(44806420) Estimation of glomerular filtration rate

198

1.11

0.14

2.3

2.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

203

1980

1.03

0.12

5.5

4.7

31.58

32.00

0.23

158

1291

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

385

0.93

0.12

1.7

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

288

1.08

0.11

1.0

1.1

6.14

5.04

u/ml

0.07

130

(3001019) Free T4 and TSH panel - Serum or Plasma

812

0.96

0.11

1.8

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

372

0.94

0.10

1.4

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.04

0.09

1.4

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

273

1.06

0.08

2.9

3.3

0.62

0.81

nmol/l

2.53

225

(3047189) Immunofixation for 24 hour Urine

1.04

0.07

1.3

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

285

0.95

0.06

1.0

0.07

0.24

u/ml

—

(1002224) Polysomnography panel

880

0.98

0.06

1.1

—

(3025577) Chromium [Mass/volume] in Blood

1.11

0.05

2.3

2.4

1.53

2.05

ug/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

358

1.03

0.04

1.0

1.1

0.64

1.56

u/ml

1.55

174

(3051387) C reactive protein [Mass/volume] in Capillary blood

341

0.97

0.03

4.5

3.2

43.00

25.83

mg/l

1.60

231

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

432

1.02

0.01

1.1

0.87

1.96

u/ml

1.00

235

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

213

1.03

0.01

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

277

0.97

0.01

1.5

41.97

56.91

ug/l

1.96

277

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.06

0.01

1.6

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

375

0.99

0.00

1.0

1.1

4.27

5.44

u/ml

0.20

201

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

116

1.03

0.00

1.3

1.5

156.02

158.53

pmol/l

0.03

116

(44813793) Dust mix specific IgE antibody measurement

107

1.03

0.00

1.1

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

363

0.99

0.00

1.0

1.1

0.28

1.40

u/ml

1.53

154

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.00

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.6

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.48

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

3.14

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

340

1.00

-0.00

2.0

1.7

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.93

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AUTOHEP_WIDE – Autoimmune hepatitis, wide definition

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Autoimmune hepatitis, wide definition

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Autoimmune hepatitis, wide definition (AUTOHEP_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints